PDB IDTitleDep. DateAuthorsPDBSumPubMed ID
6AOPA structural explanation for the low efficacy of the seasonal influenza H3N2 vaccine8/16/17Wu, N.C.; Wilson, I.A.PDBSumPubMed
6AOQA structural explanation for the low efficacy of the seasonal influenza H3N2 vaccine8/16/17Wu, N.C.; Wilson, I.A.PDBSumPubMed
6AORA structural explanation for the low efficacy of the seasonal influenza H3N2 vaccine8/16/17Wu, N.C.; Wilson, I.A.PDBSumPubMed
6AOSA structural explanation for the low efficacy of the seasonal influenza H3N2 vaccine8/16/17Wu, N.C.; Wilson, I.A.PDBSumPubMed
6AOTA structural explanation for the low efficacy of the seasonal influenza H3N2 vaccine8/16/17Wu, N.C.; Wilson, I.A.PDBSumPubMed
6AOUA structural explanation for the low efficacy of the seasonal influenza H3N2 vaccine8/16/17Wu, N.C.; Wilson, I.A.PDBSumPubMed
6AOVA structural explanation for the low efficacy of the seasonal influenza H3N2 vaccine8/16/17Wu, N.C.; Wilson, I.A.PDBSumPubMed
5W6DDesign and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo.6/16/17Garces, F.; Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
5W6IPotent peptidic fusion inhibitors of influenza virus.6/16/17Wilson, I.A.; Kadam, R.U.PDBSumPubMed
5W6RPotent peptidic fusion inhibitors of influenza virus.6/16/17Wilson, I.A.; Kadam, R.U.PDBSumPubMed
5W6TPotent peptidic fusion inhibitors of influenza virus.6/16/17Wilson, I.A.; Kadam, R.U.PDBSumPubMed
5W6UPotent peptidic fusion inhibitors of influenza virus.6/16/17Wilson, I.A.; Kadam, R.U.PDBSumPubMed
5W5SPotent peptidic fusion inhibitors of influenza virus.6/15/17Wilson, I.A.; Kadam, R.U.PDBSumPubMed
5W5UPotent peptidic fusion inhibitors of influenza virus.6/15/17Wilson, I.A.; Kadam, R.U.PDBSumPubMed
5W3QDefining the Structural Basis for Allosteric Product Release from E. coli Dihydrofolate Reductase Using NMR Relaxation Dispersion.6/8/17Oyen, D.; Wright, P.E.; Wilson, I.A.PDBSumPubMed
5VTRDiversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin.5/18/17Wu, N.C.; Wilson, I.A.PDBSumPubMed
5VTUDiversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin.5/18/17Wu, N.C.; Wilson, I.A.PDBSumPubMed
5VTVDiversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin.5/18/17Wu, N.C.; Wilson, I.A.PDBSumPubMed
5VTWDiversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin.5/18/17Wu, N.C.; Wilson, I.A.PDBSumPubMed
5VTXDiversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin.5/18/17Wu, N.C.; Wilson, I.A.PDBSumPubMed
5VTYDiversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin.5/18/17Wu, N.C.; Wilson, I.A.PDBSumPubMed
5VTZDiversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin.5/18/17Wu, N.C.; Wilson, I.A.PDBSumPubMed
5VU4Diversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin.5/18/17Wu, N.C.; Wilson, I.A.PDBSumPubMed
5VTQDiversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin.5/17/17Wu, N.C.; Wilson, I.A.PDBSumPubMed
5VLIMassively parallel de novo protein design for targeted therapeutics.4/25/17Bernard, S.M.; Wilson, I.A.PDBSumPubMed
5VJKThree mutations switch H7N9 influenza to human-type receptor specificity.4/19/17Zhu, X.; Wilson, I.A.PDBSumPubMed
5VJLThree mutations switch H7N9 influenza to human-type receptor specificity.4/19/17Zhu, X.; Wilson, I.A.PDBSumPubMed
5VJMThree mutations switch H7N9 influenza to human-type receptor specificity.4/19/17Zhu, X.; Wilson, I.A.PDBSumPubMed
5V7RImmunological memory to hyperphosphorylated tau in asymptomatic individuals.3/20/17Zhu, X.; Zhang, H.; Wilson, I.A.PDBSumPubMed
5V7UImmunological memory to hyperphosphorylated tau in asymptomatic individuals.3/20/17Zhu, X.; Zhang, H.; Wilson, I.A.PDBSumPubMed
5V2AH7N9 influenza virus neutralizing antibodies that possess few somatic mutations.3/3/17Zhang, H.; Zhu, X.; Wilson, I.A.PDBSumPubMed
5UXQA Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic Beta-Hairpin Structure2/23/17Kong, L.; Wilson, I.A.PDBSumPubMed
5UY3A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic beta-Hairpin Structure.2/23/17Julien, J.-P.; Lee, J.H.; Wilson, I.A.PDBSumPubMed
5UMNIn vitro evolution of an influenza broadly neutralizing antibody is modulated by hemagglutinin receptor specificity.1/27/17Wu, N.C.; Wilson, I.A.PDBSumPubMed
5UM8Glycine Substitution at Helix-to-Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein.1/26/17Garces, F.; Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
5UFBStructural Insights into VLR Fine Specificity for Blood Group Carbohydrates.1/4/17Collins, B.C.; Gunn, R.J.; McKitrick, T.R.; Cummings, R.D.; Cooper, M.D.; Herrin, B.R.; Wilson, I.A.PDBSumPubMed
5UFCStructural Insights into VLR Fine Specificity for Blood Group Carbohydrates.1/4/17Collins, B.C.; Gunn, R.J.; McKitrick, T.R.; Cummings, R.D.; Cooper, M.D.; Herrin, B.R.; Wilson, I.A.PDBSumPubMed
5UFDStructural Insights into VLR Fine Specificity for Blood Group Carbohydrates.1/4/17Collins, B.C.; Gunn, R.J.; McKitrick, T.R.; Herrin, B.R.; Cummings, R.D.; Cooper, M.D.; Wilson, I.A.PDBSumPubMed
5UFFStructural Insights into VLR Fine Specificity for Blood Group Carbohydrates.1/4/17Collins, B.C.; Gunn, R.J.; McKitrick, T.R.; Herrin, B.R.; Cummings, R.D.; Cooper, M.D.; Wilson, I.A.PDBSumPubMed
5UF1Structural Insights into VLR Fine Specificity for Blood Group Carbohydrates.1/3/17Gunn, R.J.; Bernard, C.C.; McKitrick, T.R.; Cummings, R.D.; Cooper, M.D.; Herrin, B.R.; Wilson, I.A.PDBSumPubMed
5UF4Structural Insights into VLR Fine Specificity for Blood Group Carbohydrates.1/3/17Gunn, R.J.; Bernard, C.C.; McKitrick, T.R.; Cummings, R.D.; Cooper, M.D.; Herrin, B.R.; Wilson, I.A.PDBSumPubMed
5UEIStructural Insights into VLR Fine Specificity for Blood Group Carbohydrates.1/2/17Gunn, R.J.; Collins, B.C.; McKitrick, T.R.; Cummings, R.D.; Herrin, B.R.; Cooper, M.D.; Wilson, I.A.PDBSumPubMed
5U7GRole of the CBP catalytic core in intramolecular SUMOylation and control of histone H3 acetylation.12/12/16Park, S.; Stanfield, R.L.; Martinez-Yamout, M.M.; Dyson, H.J.; Wilson, I.A.; Wright, P.E.PDBSumPubMed
5U64Selection of nanobodies with broad neutralizing potential against primary HIV-1 strains using soluble subtype C gp140 envelope trimers.12/7/16Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
5U65Selection of nanobodies with broad neutralizing potential against primary HIV-1 strains using soluble subtype C gp140 envelope trimers.12/7/16Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
5U36Genetically encoding phosphotyrosine and its nonhydrolyzable analog in bacteria.12/1/16Luo, X.; Fu, G.; Zhu, X.; Wilson, I.A.; Wang, F.PDBSumPubMed
5TZLSemi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.11/21/16Connelly, S.; Mortenson, D.E.; Choi, S.; Wilson, I.A.; Powers, E.T.; Kelly, J.W.; Johnson, S.M.PDBSumPubMed
5THBThe 150-Loop Restricts the Host Specificity of Human H10N8 Influenza Virus.9/29/16Tzarum, N.; Wilson, I.A.PDBSumPubMed
5THCThe 150-Loop Restricts the Host Specificity of Human H10N8 Influenza Virus.9/29/16Tzarum, N.; Wilson, I.A.PDBSumPubMed
5THFThe 150-Loop Restricts the Host Specificity of Human H10N8 Influenza Virus.9/29/16Tzarum, N.; Wilson, I.A.PDBSumPubMed
5TGOThe 150-Loop Restricts the Host Specificity of Human H10N8 Influenza Virus.9/28/16Tzarum, N.; Wilson, I.A.PDBSumPubMed
5TGUThe 150-Loop Restricts the Host Specificity of Human H10N8 Influenza Virus.9/28/16Tzarum, N.; Wilson, I.A.PDBSumPubMed
5TGVThe 150-Loop Restricts the Host Specificity of Human H10N8 Influenza Virus.9/28/16Tzarum, N.; Wilson, I.A.PDBSumPubMed
5TH0The 150-Loop Restricts the Host Specificity of Human H10N8 Influenza Virus.9/28/16Tzarum, N.; Wilson, I.A.PDBSumPubMed
5TH1The 150-Loop Restricts the Host Specificity of Human H10N8 Influenza Virus.9/28/16Tzarum, N.; Wilson, I.A.PDBSumPubMed
5TG8Unique Structural Features of Influenza Virus H15 Hemagglutinin.9/27/16Wilson, I.A.; Tzarum, N.PDBSumPubMed
5TG9Unique Structural Features of Influenza Virus H15 Hemagglutinin.9/27/16Wilson, I.A.; Tzarum, N.PDBSumPubMed
5TFWLipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design.9/26/16Irimia, A.; Wilson, I.A.PDBSumPubMed
5T80Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design.9/6/16Irimia, A.; Wilson, I.A.PDBSumPubMed
5T85Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design.9/6/16Irimia, A.; Wilson, I.A.PDBSumPubMed
5T6LLipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design.9/1/16Irimia, A.; Wilson, I.A.PDBSumPubMed
5T6NStructural basis of influenza virus fusion inhibition by the antiviral drug Arbidol.9/1/16Kadam, R.U.; Wilson, I.A.PDBSumPubMed
5T6SStructural basis of influenza virus fusion inhibition by the antiviral drug Arbidol.9/1/16Kadam, R.U.; Wilson, I.A.PDBSumPubMed
5T5BLipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design.8/30/16Irimia, A.; Wilson, I.A.PDBSumPubMed
5T3SHIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies.8/26/16Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
5T29Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design.8/23/16Irimia, A.; Wilson, I.A.PDBSumPubMed
5T08A single mutation in Taiwanese H6N1 influenza hemagglutinin switches binding to human-type receptors.8/15/16Wilson, I.A.; Tzarum, N.; Zhu, X.PDBSumPubMed
5T0BA single mutation in Taiwanese H6N1 influenza hemagglutinin switches binding to human-type receptors.8/15/16Wilson, I.A.; Tzarum, N.; Zhu, X.PDBSumPubMed
5T0DA single mutation in Taiwanese H6N1 influenza hemagglutinin switches binding to human-type receptors.8/15/16Wilson, I.A.; Tzarum, N.; Zhu, X.PDBSumPubMed
5T0EA single mutation in Taiwanese H6N1 influenza hemagglutinin switches binding to human-type receptors.8/15/16Wilson, I.A.; Tzarum, N.; Zhu, X.PDBSumPubMed
5SY8Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design.8/10/16Irimia, A.; Wilson, I.A.PDBSumPubMed
5KZCMinimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design.7/24/16Julien, J.-P.; Jardine, J.G.; Diwanji, D.; Schief, W.R.; Wilson, I.A.PDBSumPubMed
5KUXComputational design of trimeric influenza-neutralizing proteins targeting the hemagglutinin receptor binding site.7/13/16Lee, P.S.; Bernard, S.M.; Wilson, I.A.PDBSumPubMed
5KUYComputational design of trimeric influenza-neutralizing proteins targeting the hemagglutinin receptor binding site.7/13/16Bernard, S.M.; Wilson, I.A.PDBSumPubMed
5JS9Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability.5/7/16Kong, L.; Wilson, I.A.PDBSumPubMed
5JSAUncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability.5/7/16Kong, L.; Wilson, I.A.PDBSumPubMed
5JOPT cells control the generation of nanomolar-affinity anti-glycan antibodies.5/2/16Sarkar, A.; Irimia, A.; Teyton, L.; Wilson, I.A.PDBSumPubMed
5JORT cells control the generation of nanomolar-affinity anti-glycan antibodies.5/2/16Sarkar, A.; Irimia, A.; Teyton, L.; Wilson, I.A.PDBSumPubMed
5J74Discovery of Small-Molecule Nonfluorescent Inhibitors of Fluorogen-Fluorogen Activating Protein Binding Pair.4/5/16Stanfield, R.L.; Wilson, I.A.; Wu, Y.PDBSumPubMed
5J75Discovery of Small-Molecule Nonfluorescent Inhibitors of Fluorogen-Fluorogen Activating Protein Binding Pair.4/5/16Stanfield, R.L.; Wilson, I.A.; Wu, Y.PDBSumPubMed
5ILTConservation and diversity in the ultralong third heavy-chain complementarity-determining region of bovine antibodies.3/4/16Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
5IJVConservation and diversity in the ultralong third heavy-chain complementarity-determining region of bovine antibodies.3/2/16Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
5IHUConservation and diversity in the ultralong third heavy-chain complementarity-determining region of bovine antibodies.2/29/16Stanfield, R.; Wilson, I.PDBSumPubMed
5IESHIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen.2/25/16Sarkar, A.; Wilson, I.A.PDBSumPubMed
5IF0HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen.2/25/16Sarkar, A.; Wilson, I.A.PDBSumPubMed
5IFAHIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen.2/25/16Sarkar, A.; Wilson, I.A.PDBSumPubMed
5IDLHIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen.2/24/16Julien, J.P.; Ereno-Orbea, J.; Jardine, J.G.; Schief, W.R.; Wilson, I.A.PDBSumPubMed
5HZQArylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue.2/2/16Chen, W.; Mortenson, D.E.; Wilson, I.A.; Kelly, J.W.PDBSumPubMed
5FEHEvolutive features of HIV-1 Env critical for initiation and maturation of broadly neutralizing antibodies to the V2-apex12/17/15Murrell, S.; Wilson, I.A.PDBSumPubMed
5E99Conservation and diversity in the ultralong third heavy-chain complementarity-determining region of bovine antibodies.10/14/15Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
5E2YStructural Basis for a Switch in Receptor Binding Specificity of Two H5N1 Hemagglutinin Mutants.10/1/15Zhu, X.; Wilson, I.A.PDBSumPubMed
5E2ZStructural Basis for a Switch in Receptor Binding Specificity of Two H5N1 Hemagglutinin Mutants.10/1/15Zhu, X.; Wilson, I.A.PDBSumPubMed
5E30Structural Basis for a Switch in Receptor Binding Specificity of Two H5N1 Hemagglutinin Mutants.10/1/15Zhu, X.; Wilson, I.A.PDBSumPubMed
5E32Structural Basis for a Switch in Receptor Binding Specificity of Two H5N1 Hemagglutinin Mutants.10/1/15Zhu, X.; Wilson, I.A.PDBSumPubMed
5E34Structural Basis for a Switch in Receptor Binding Specificity of Two H5N1 Hemagglutinin Mutants.10/1/15Zhu, X.; Wilson, I.A.PDBSumPubMed
5E35Structural Basis for a Switch in Receptor Binding Specificity of Two H5N1 Hemagglutinin Mutants.10/1/15Zhu, X.; Wilson, I.A.PDBSumPubMed
5D9QMinimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design.8/18/15Julien, J.-P.; Stanfield, R.L.; Ward, A.B.; Wilson, I.A.PDBSumPubMed
5CJSA stable trimeric influenza hemagglutinin stem as a broadly protective immunogen.7/15/15Zhu, X.; Wilson, I.A.PDBSumPubMed
5CJQA stable trimeric influenza hemagglutinin stem as a broadly protective immunogen.7/14/15Zhu, X.; Wilson, I.A.PDBSumPubMed
5CEZAffinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans.7/8/15Wilson, I.A.; Garces, F.PDBSumPubMed
5CEXAffinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans.7/7/15Garces, F.; Wilson, I.A.PDBSumPubMed
5CEYAffinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans.7/7/15Wilson, I.A.; Garces, F.PDBSumPubMed
5AWNAntibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike.7/6/15Lee, J.H.; Wilson, I.A.; Ward, A.B.PDBSumPubMed
5CD5Critical determinants in the emergence of broadly neutralizing CD4-binding site antibodies from an HIV-1-infected Chinese donor7/3/15Kong, L.; Wilson, I.A.PDBSumPubMed
5CCKAntibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike.7/2/15Lee, J.H.; Ward, A.B.; Wilson, I.A.PDBSumPubMed
5CD3Critical determinants in the emergence of broadly neutralizing CD4-binding site antibodies from an HIV-1-infected Chinese donor7/2/15Kong, L.; Wilson, I.A.PDBSumPubMed
5C7KComplete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer.6/24/15Kong, L.; Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
5BZDEarly Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch6/11/15Garces, F.; WILSON, I.A.PDBSumPubMed
5BZWEarly Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch6/11/15Garces, F.; WILSON, I.A.PDBSumPubMed
4ZCJDesign and Structure of an Engineered Disulfide-Stabilized Influenza Virus Hemagglutinin Trimer.4/16/15Lee, P.S.; Wilson, I.A.PDBSumPubMed
4YAQRedesigned HIV antibodies exhibit enhanced neutralizing potency and breadth.2/17/15Murrell, S.; Julien, J.P.; Wilson, I.A.PDBSumPubMed
4XQUA Human-Infecting H10N8 Influenza Virus Retains a Strong Preference for Avian-type Receptors.1/20/15Tzarum, N.; Zhang, H.; Zhu, X.; Wilson, I.A.PDBSumPubMed
4XQ5A Human-Infecting H10N8 Influenza Virus Retains a Strong Preference for Avian-type Receptors.1/19/15Tzarum, N.; Zhang, H.; Zhu, X.; Wilson, I.A.PDBSumPubMed
4XQOA Human-Infecting H10N8 Influenza Virus Retains a Strong Preference for Avian-type Receptors.1/19/15Tzarum, N.; Zhang, H.; Zhu, X.; Wilson, I.A.PDBSumPubMed
4XKDStructure and Receptor Binding of the Hemagglutinin from a Human H6N1 Influenza Virus.1/11/15Tzarum, N.; Zhu, X.; Wilson, I.A.PDBSumPubMed
4XKEStructure and Receptor Binding of the Hemagglutinin from a Human H6N1 Influenza Virus.1/11/15Tzarum, N.; Zhu, X.; Wilson, I.A.PDBSumPubMed
4XKFStructure and Receptor Binding of the Hemagglutinin from a Human H6N1 Influenza Virus.1/11/15Tzarum, N.; Zhu, X.; Wilson, I.A.PDBSumPubMed
4XKGStructure and Receptor Binding of the Hemagglutinin from a Human H6N1 Influenza Virus.1/11/15Tzarum, N.; Zhu, X.; Wilson, I.A.PDBSumPubMed
4XCNCrystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10.12/18/14Irimia, A.; Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
4XCYCrystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10.12/18/14Irimia, A.; Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
4XBPCrystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10.12/17/14Irimia, A.; Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
4XC1Crystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10.12/17/14Irimia, A.; Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
4XC3Crystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10.12/17/14Irimia, A.; Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
4XCCCrystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10.12/17/14Irimia, A.; Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
4XCECrystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10.12/17/14Irimia, A.; Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
4XCFCrystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10.12/17/14Irimia, A.; Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
4XBECrystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10.12/16/14Irimia, A.; Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
4XBGCrystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10.12/16/14Irimia, A.; Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
4XAWCrystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10.12/15/14Irimia, A.; Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
4RQSCrystal structure of a fully glycosylated HIV-1 gp120 core reveals a stabilizing role for the glycan at Asn262.11/5/14Kong, L.; Wilson, I.A.; Kwong, P.D.PDBSumPubMed
4RQQRecombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex.11/4/14Julien, J.-P.; Wilson, I.A.PDBSumPubMed
4WUKStructure of the apo anti-influenza CH65 Fab.11/1/14Lee, P.S.; Wilson, I.A.PDBSumPubMed
4RNRTwo Classes of Broadly Neutralizing Antibodies within a Single Lineage Directed to the High-Mannose Patch of HIV Envelope.10/24/14Kong, L.; Wilson, I.A.PDBSumPubMed
4RBPCrystal structure of the HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomannose.9/12/14Stanfield, R.L.; Wilson, I.A.; De Castro, C.; Marzaioli, A.M.; Pantophlet, R.PDBSumPubMed
4R2GStructural Evolution of Glycan Recognition by a Family of Potent HIV Antibodies.8/11/14Garces, F.; Wilson, I.A.PDBSumPubMed
4R26Structural Evolution of Glycan Recognition by a Family of Potent HIV Antibodies.8/8/14Garces, F.; Kong, L.; Wilson, I.A.PDBSumPubMed
4QGTStabilizing the CH2 Domain of an Antibody by Engineering in an Enhanced Aromatic Sequon.5/25/14Kong, L.; Connelly, S.C.; Wilson, I.A.PDBSumPubMed
4QDHCrystal structure of the C-terminal domain of mouse TLR9.5/13/14Collins, B.C.; Wilson, I.A.PDBSumPubMed
4O58Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus.12/19/13Lee, P.S.; Wilson, I.A.PDBSumPubMed
4O5IReceptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus.12/19/13Lee, P.S.; Wilson, I.A.PDBSumPubMed
4O5LReceptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus.12/19/13Lee, P.S.; Wilson, I.A.PDBSumPubMed
4O5NReceptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus.12/19/13Lee, P.S.; Wilson, I.A.PDBSumPubMed
4NZRA structurally distinct human mycoplasma protein that generically blocks antigen-antibody union.12/12/13Zhu, X.; Wilson, I.A.PDBSumPubMed
4NZTA structurally distinct human mycoplasma protein that generically blocks antigen-antibody union.12/12/13Zhu, X.; Wilson, I.A.PDBSumPubMed
4NZUA structurally distinct human mycoplasma protein that generically blocks antigen-antibody union.12/12/13Zhu, X.; Wilson, I.A.PDBSumPubMed
4NWTNucleotide insertions and deletions complement point mutations to massively expand the diversity created by somatic hypermutation of antibodies.12/6/13Verdino, P.; Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
4NWUNucleotide insertions and deletions complement point mutations to massively expand the diversity created by somatic hypermutation of antibodies.12/6/13Verdino, P.; Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
4NUGStructural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers.12/3/13Blattner, C.; Wilson, I.A.PDBSumPubMed
4NUJStructural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers.12/3/13Blattner, C.; Wilson, I.A.PDBSumPubMed
4NPYThe Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies.11/22/13Julien, J.-P.; Diwanji, D.C.; Wilson, I.A.PDBSumPubMed
4NM4A common solution to group 2 influenza virus neutralization.11/14/13Lee, P.S.; Wilson, I.A.PDBSumPubMed
4NM8A common solution to group 2 influenza virus neutralization.11/14/13Lee, P.S.; Wilson, I.A.PDBSumPubMed
4NJ9Adaptive Mutations Alter Antibody Structure and Dynamics during Affinity Maturation.11/8/13Stanfield, R.L.; Romesberg, F.E.; Zimmermann, J.; Wilson, I.A.PDBSumPubMed
4NJAAdaptive Mutations Alter Antibody Structure and Dynamics during Affinity Maturation.11/8/13Stanfield, R.L.; Romesberg, F.E.; Zimmermann, J.; Wilson, I.A.PDBSumPubMed
4NHCStapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies.11/4/13Irimia, A.; Wilson, I.A.PDBSumPubMed
4NGHStapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies.11/1/13Irimia, A.; Wilson, I.A.PDBSumPubMed
3J5MCryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer.10/26/13Lyumkis, D.; Julien, J.-P.; Wilson, I.A.; Ward, A.B.PDBSumPubMed
4NCOCrystal structure of a soluble cleaved HIV-1 envelope trimer.10/24/13Julien, J.-P.; Stanfield, R.L.; Lyumkis, D.; Ward, A.B.; Wilson, I.A.PDBSumPubMed
4N60Preferential recognition of avian-like receptors in human influenza A H7N9 viruses.10/11/13Xu, R.; Wilson, I.A.PDBSumPubMed
4N61Preferential recognition of avian-like receptors in human influenza A H7N9 viruses.10/11/13Xu, R.; Wilson, I.A.PDBSumPubMed
4N62Preferential recognition of avian-like receptors in human influenza A H7N9 viruses.10/11/13Xu, R.; Wilson, I.A.PDBSumPubMed
4N63Preferential recognition of avian-like receptors in human influenza A H7N9 viruses.10/11/13Xu, R.; Wilson, I.A.PDBSumPubMed
4N64Preferential recognition of avian-like receptors in human influenza A H7N9 viruses.10/11/13Xu, R.; Wilson, I.A.PDBSumPubMed
4N5JPreferential recognition of avian-like receptors in human influenza A H7N9 viruses.10/10/13Xu, R.; Wilson, I.A.PDBSumPubMed
4N5KPreferential recognition of avian-like receptors in human influenza A H7N9 viruses.10/10/13Xu, R.; Wilson, I.A.PDBSumPubMed
4N5YHemagglutinin Receptor Specificity and Structural Analyses of Respiratory Droplet-Transmissible H5N1 Viruses.10/10/13Zhu, X.; Wilson, I.A.PDBSumPubMed
4N5ZHemagglutinin Receptor Specificity and Structural Analyses of Respiratory Droplet-Transmissible H5N1 Viruses.10/10/13Zhu, X.; Wilson, I.A.PDBSumPubMed
4N0YStructure of Hepatitis C Virus Envelope Glycoprotein E1 Antigenic Site 314-324 in Complex with Antibody IGH526.10/2/13Kong, L.; Wilson, I.A.PDBSumPubMed
4MZEInteraction between the hemagglutinin-neuraminidase and fusion glycoproteins of human parainfluenza virus type III regulates viral growth in vivo.9/30/13Xu, R.; Wilson, I.A.PDBSumPubMed
4MZAInteraction between the hemagglutinin-neuraminidase and fusion glycoproteins of human parainfluenza virus type III regulates viral growth in vivo.9/29/13Xu, R.; Wilson, I.A.PDBSumPubMed
4MWFHepatitis C virus e2 envelope glycoprotein core structure.9/24/13Kong, L.; Wilson, I.A.; Law, M.PDBSumPubMed
4MHHA Unique and Conserved Neutralization Epitope in H5N1 Influenza Viruses Identified by an Antibody against the A/Goose/Guangdong/1/96 Hemagglutinin.8/29/13Zhu, X.; Wilson, I.A.PDBSumPubMed
4MHIA Unique and Conserved Neutralization Epitope in H5N1 Influenza Viruses Identified by an Antibody against the A/Goose/Guangdong/1/96 Hemagglutinin.8/29/13Zhu, X.; Wilson, I.A.PDBSumPubMed
4MHJA Unique and Conserved Neutralization Epitope in H5N1 Influenza Viruses Identified by an Antibody against the A/Goose/Guangdong/1/96 Hemagglutinin.8/29/13Zhu, X.; Wilson, I.A.PDBSumPubMed
4MASHigh Resolution Structure of Wild Type Human Transthyretin in Complex with 3,3',5,5'-tetrachloro-[1,1'-biphenyl]-4,4'diol8/16/13Connelly, S.; Bradbury, N.C.; Wilson, I.A.PDBSumPubMed
4M6JDivergent evolution of protein conformational dynamics in dihydrofolate reductase.8/9/13Bhabha, G.; Ekiert, D.C.; Wright, P.E.; Wilson, I.A.PDBSumPubMed
4M6KDivergent evolution of protein conformational dynamics in dihydrofolate reductase.8/9/13Bhabha, G.; Ekiert, D.C.; Wright, P.E.; Wilson, I.A.PDBSumPubMed
4M6LDivergent evolution of protein conformational dynamics in dihydrofolate reductase.8/9/13Bhabha, G.; Ekiert, D.C.; Wright, P.E.; Wilson, I.A.PDBSumPubMed
4M5YAntibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding Site.8/8/13Lee, P.S.; Wilson, I.A.PDBSumPubMed
4M5ZAntibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding Site.8/8/13Hong, M.; Lee, P.S.; Wilson, I.A.PDBSumPubMed
4M61Crystal structure determination of anti-DNA Fab A52.8/8/13Stanfield, R.L.; Eilat, D.; Wilson, I.A.PDBSumPubMed
4M4YAntibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding Site.8/7/13Zhu, X.; Wilson, I.A.PDBSumPubMed
4M43Crystal structure of anti-rabies glycoprotein Fab 523-118/6/13Stanfield, R.L.; Wilson, I.A.; Wunner, W.H.PDBSumPubMed
4LG2Ebolavirus VP35 coats the backbone of double-stranded RNA for interferon antagonism.6/27/13Bale, S.; Julien, J-P.; Bornholdt, Z.A.; Krois, A.S.; Wilson, I.A.; Saphire, E.O.PDBSumPubMed
4L1SFluorogenic small molecules requiring reaction with a specific protein to create a fluorescent conjugate for biological imaging-what we know and what we need to learn.6/3/13Connelly, S.; Wilson, I.A.PDBSumPubMed
4L1TFluorogenic small molecules requiring reaction with a specific protein to create a fluorescent conjugate for biological imaging-what we know and what we need to learn.6/3/13Connelly, S.; Wilson, I.A.PDBSumPubMed
4KY2Bifunctional coumarin derivatives that inhibit transthyretin amyloidogenesis and serve as fluorescent transthyretin folding sensors.5/28/13Connelly, S.; Wilson, I.A.; Choi, S.PDBSumPubMed
4K3XNew world bats harbor diverse influenza a viruses.4/11/13Zhu, X.; Wilson, I.A.PDBSumPubMed
4K3YNew world bats harbor diverse influenza a viruses.4/11/13Zhu, X.; Wilson, I.A.PDBSumPubMed
4K3DReshaping antibody diversity.4/10/13Ekiert, D.C.; Wang, F.; Wilson, I.A.PDBSumPubMed
4K3EReshaping antibody diversity.4/10/13Ekiert, D.C.; Wang, F.; Wilson, I.A.PDBSumPubMed
4K3GMalachite Green Mediates Homodimerization of Antibody VL Domains to Form a Fluorescent Ternary Complex with Singular Symmetric Interfaces.4/10/13Stanfield, R.L.; Szent-Gyorgyi, C.; Wilson, I.A.PDBSumPubMed
4K3HMalachite Green Mediates Homodimerization of Antibody VL Domains to Form a Fluorescent Ternary Complex with Singular Symmetric Interfaces.4/10/13Stanfield, R.L.; Szent-Gyorgyi, C.; Wilson, I.A.PDBSumPubMed
4JY4Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans.3/29/13Julien, J.-P.; Diwanji, D.C.; Burton, D.R.; Wilson, I.A.PDBSumPubMed
4JY5Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans.3/29/13Julien, J.-P.; Diwanji, D.C.; Burton, D.R.; Wilson, I.A.PDBSumPubMed
4JY6Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans.3/29/13Julien, J.-P.; Diwanji, D.C.; Burton, D.R.; Wilson, I.A.PDBSumPubMed
4JPIRational HIV immunogen design to target specific germline B cell receptors.3/19/13Julien, J.-P.; Diwanji, D.C.; Jardine, J.; Schief, W.R.; Wilson, I.A.PDBSumPubMed
4JPJRational HIV immunogen design to target specific germline B cell receptors.3/19/13Julien, J.-P.; Jardine, J.; Schief, W.R.; Wilson, I.A.PDBSumPubMed
4JPKRational HIV immunogen design to target specific germline B cell receptors.3/19/13Julien, J.-P.; Jardine, J.; Schief, W.R.; Wilson, I.A.PDBSumPubMed
4JM2Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120.3/13/13Kong, L.; Wilson, I.A.PDBSumPubMed
4JM4Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120.3/13/13Kong, L.; Wilson, I.A.PDBSumPubMed
4I78Hemagglutinin homologue from H17N10 bat influenza virus exhibits divergent receptor-binding and pH-dependent fusion activities.11/30/12Zhu, X.; Wilson, I.A.PDBSumPubMed
4HLZStructure of a classical broadly neutralizing stem antibody in complex with a pandemic h2 influenza virus hemagglutinin.10/17/12Dreyfus, C.; Wilson, I.A.PDBSumPubMed
4HJSStilbene vinyl sulfonamides as fluorogenic sensors of and traceless covalent kinetic stabilizers of transthyretin that prevent amyloidogenesis.10/14/12Connelly, S.; Wilson, I.A.PDBSumPubMed
4HJTStilbene vinyl sulfonamides as fluorogenic sensors of and traceless covalent kinetic stabilizers of transthyretin that prevent amyloidogenesis.10/14/12Connelly, S.; Wilson, I.A.PDBSumPubMed
4HJUStilbene vinyl sulfonamides as fluorogenic sensors of and traceless covalent kinetic stabilizers of transthyretin that prevent amyloidogenesis.10/14/12Connelly, S.; Wilson, I.A.PDBSumPubMed
4HIQAG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.10/11/12Connelly, S.; Alhamadsheh, M.; Graef, I.; Wilson, I.A.PDBSumPubMed
4HISAG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.10/11/12Connelly, S.; Alhamadsheh, M.; Graef, I.; Wilson, I.A.PDBSumPubMed
2YMNOrganization of the Influenza Virus Replication Machinery.10/9/12Moeller, A.; Kirchdoerfer, R.N.; Potter, C.S.; Carragher, B.; Wilson, I.A.PDBSumPubMed
4HG4A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin.10/6/12Xu, R.; Wilson, I.A.PDBSumPubMed
4HFUA recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin.10/5/12Xu, R.; Wilson, I.A.PDBSumPubMed
4HF5A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin.10/4/12Xu, R.; Wilson, I.A.PDBSumPubMed
4GZOInfluenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic Acid receptors.9/6/12Zhu, X.; Wilson, I.A.PDBSumPubMed
4GZPInfluenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic Acid receptors.9/6/12Zhu, X.; Wilson, I.A.PDBSumPubMed
4GZQInfluenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic Acid receptors.9/6/12Zhu, X.; Wilson, I.A.PDBSumPubMed
4GZSInfluenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic Acid receptors.9/6/12Zhu, X.; Wilson, I.A.PDBSumPubMed
4GZTInfluenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic Acid receptors.9/6/12Zhu, X.; Wilson, I.A.PDBSumPubMed
4GZWInfluenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic Acid receptors.9/6/12Zhu, X.; Wilson, I.A.PDBSumPubMed
4GZXInfluenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic Acid receptors.9/6/12Zhu, X.; Wilson, I.A.PDBSumPubMed
4GXUInfluenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 Viruses.9/4/12Ekiert, D.C.; Wilson, I.A.PDBSumPubMed
4GXVInfluenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 Viruses.9/4/12Ekiert, D.C.; Wilson, I.A.PDBSumPubMed
4GXXInfluenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 Viruses.9/4/12Ekiert, D.C.; Wilson, I.A.PDBSumPubMed
4GMSHeterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity.8/16/12Lee, P.S.; Ekiert, D.C.; Wilson, I.A.PDBSumPubMed
4GMTHeterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity.8/16/12Lee, P.S.; Ekiert, D.C.; Wilson, I.A.PDBSumPubMed
4GH9Marburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon Antagonism.8/7/12Bale, S.; Jean-Philippe, J.; Bornholdt, Z.A.; Kimberlin, C.K.; Halfmann, P.; Zandonatti, M.A.; Kunert, J.; Kroon, G.J.A.; Kawaoka, Y.; MacRae, I.J.; Wilson, I.A.; Saphire, E.O.PDBSumPubMed
4GHAMarburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon Antagonism.8/7/12Bale, S.; Jean-Philippe, J.; Bornholdt, Z.A.; Kimberlin, C.K.; Halfmann, P.; Zandonatti, M.A.; Kunert, J.; Kroon, G.J.A.; Kawaoka, Y.; MacRae, I.J.; Wilson, I.A.; Saphire, E.O.PDBSumPubMed
4GDICrystal structures of two subtype N10 neuraminidase-like proteins from bat influenza A viruses reveal a diverged putative active site.7/31/12Zhu, X.; Wilson, I.A.PDBSumPubMed
4GDJCrystal structures of two subtype N10 neuraminidase-like proteins from bat influenza A viruses reveal a diverged putative active site.7/31/12Zhu, X.; Wilson, I.A.PDBSumPubMed
4G6AStructure of Hepatitis C Virus Envelope Glycoprotein E2 Antigenic Site 412 to 423 in Complex with Antibody AP33.7/18/12Kong, L.; Wilson, I.A.; Law, M.PDBSumPubMed
4FQHHighly conserved protective epitopes on influenza B viruses.6/25/12Dreyfus, C.; Wilson, I.A.PDBSumPubMed
4FQIHighly conserved protective epitopes on influenza B viruses.6/25/12Dreyfus, C.; Wilson, I.A.PDBSumPubMed
4FQJHighly conserved protective epitopes on influenza B viruses.6/25/12Dreyfus, C.; Laursen, N.S.; Wilson, I.A.PDBSumPubMed
4FQKHighly conserved protective epitopes on influenza B viruses.6/25/12Dreyfus, C.; Laursen, N.S.; Wilson, I.A.PDBSumPubMed
4FQLHighly conserved protective epitopes on influenza B viruses.6/25/12Dreyfus, C.; Laursen, N.S.; Wilson, I.A.PDBSumPubMed
4FQMHighly conserved protective epitopes on influenza B viruses.6/25/12Dreyfus, C.; Laursen, N.S.; Wilson, I.A.PDBSumPubMed
4FQRCross-neutralization of influenza A viruses mediated by a single antibody loop.6/25/12Ekiert, D.C.; Wilson, I.A.PDBSumPubMed
4FQVHighly conserved protective epitopes on influenza B viruses.6/25/12Ekiert, D.C.; Dreyfus, C.; Wilson, I.A.PDBSumPubMed
4FQYHighly conserved protective epitopes on influenza B viruses.6/25/12Ekiert, D.C.; Dreyfus, C.; Wilson, I.A.PDBSumPubMed
4FP8Cross-neutralization of influenza A viruses mediated by a single antibody loop.6/21/12Ekiert, D.C.; Wilson, I.A.PDBSumPubMed
4FNKCross-neutralization of influenza A viruses mediated by a single antibody loop.6/19/12Ekiert, D.C.; Wilson, I.A.PDBSumPubMed
4FNLCross-neutralization of influenza A viruses mediated by a single antibody loop.6/19/12Ekiert, D.C.; Wilson, I.A.PDBSumPubMed
4FI6Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate.6/8/12Connelly, S.; Grimster, N.; Wilson, I.A.; Kelly, J.W.PDBSumPubMed
4FI7Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate.6/8/12Connelly, S.; Grimster, N.; Wilson, I.A.; Kelly, J.W.PDBSumPubMed
4FI8Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate.6/8/12Connelly, S.; Grimster, N.; Wilson, I.A.; Kelly, J.W.PDBSumPubMed
2LT7Molecular basis for recognition of methylated and specific DNA sequences by the zinc finger protein Kaiso.5/15/12Buck-Koehntop, B.A.; Stanfield, R.L.; Ekiert, D.C.; Martinez-Yamout, M.A.; Dyson, H.; Wilson, I.A.; Wright, P.E.PDBSumPubMed
4F6MMolecular basis for recognition of methylated and specific DNA sequences by the zinc finger protein Kaiso.5/15/12Buck-Koehntop, B.A.; Stanfield, R.L.; Ekiert, D.C.; Martinez-Yamout, M.A.; Dyson, H.J.; Wilson, I.A.; Wright, P.E.PDBSumPubMed
4F6NMolecular basis for recognition of methylated and specific DNA sequences by the zinc finger protein Kaiso.5/15/12Buck-Koehntop, B.A.; Stanfield, R.L.; Ekiert, D.C.; Martinez-Yamout, M.A.; Dyson, H.J.; Wilson, I.A.; Wright, P.E.PDBSumPubMed
4F3ZFunctional Balance of the Hemagglutinin and Neuraminidase Activities Accompanies the Emergence of the 2009 H1N1 Influenza Pandemic.5/9/12Xu, R.; Wilson, I.A.PDBSumPubMed
4EW1Biological and Structural Evaluation of 10R- and 10S-Methylthio-DDACTHF Reveals a New Role for Sulfur in Inhibition of Glycinamide Ribonucleotide Transformylase.4/26/12Connelly, S.; DeMartino, K.; Boger, D.L.; Wilson, I.A.PDBSumPubMed
4EW2Biological and Structural Evaluation of 10R- and 10S-Methylthio-DDACTHF Reveals a New Role for Sulfur in Inhibition of Glycinamide Ribonucleotide Transformylase.4/26/12Connelly, S.; DeMartino, K.; Boger, D.L.; Wilson, I.A.PDBSumPubMed
4EW3Biological and Structural Evaluation of 10R- and 10S-Methylthio-DDACTHF Reveals a New Role for Sulfur in Inhibition of Glycinamide Ribonucleotide Transformylase.4/26/12Connelly, S.; DeMartino, K.; Boger, D.L.; Wilson, I.A.PDBSumPubMed
4EEFOptimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing.3/28/12Dreyfus, C.; Wilson, I.A.PDBSumPubMed
4DGYStructural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1.1/27/12Kong, L.; Wilson, I.A.; Law, M.PDBSumPubMed
4DGVStructural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1.1/26/12Kong, L.; Wilson, I.A.; Law, M.PDBSumPubMed
3V44Structural basis of TLR5-flagellin recognition and signaling.12/14/11Yoon, S.I.; Hong, H.; Wilson, I.A.PDBSumPubMed
3V47Structural basis of TLR5-flagellin recognition and signaling.12/14/11Yoon, S.I.; Hong, H.; Wilson, I.A.PDBSumPubMed
3UN9Structure and Functional Characterization of the RNA-Binding Element of the NLRX1 Innate Immune Modulator.11/15/11Hong, M.; Yoon, S.I.; Wilson, I.A.PDBSumPubMed
3UBEStructural Characterization of the Hemagglutinin Receptor Specificity from the 2009 H1N1 Influenza Pandemic.10/24/11Xu, R.; Wilson, I.A.PDBSumPubMed
3UBJStructural Characterization of the Hemagglutinin Receptor Specificity from the 2009 H1N1 Influenza Pandemic.10/24/11Xu, R.; Wilson, I.A.PDBSumPubMed
3UBNStructural Characterization of the Hemagglutinin Receptor Specificity from the 2009 H1N1 Influenza Pandemic.10/24/11Xu, R.; Wilson, I.A.PDBSumPubMed
3UBQStructural Characterization of the Hemagglutinin Receptor Specificity from the 2009 H1N1 Influenza Pandemic.10/24/11Xu, R.; Wilson, I.A.PDBSumPubMed
3U1SStructure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9.9/30/11Julien, J.-P.; Diwanji, D.; Burton, D.R.; Wilson, I.A.PDBSumPubMed
3TYJVariable Lymphocyte Receptor Recognition of the Immunodominant Glycoprotein of Bacillus anthracis Spores.9/26/11Kirchdoerfer, R.N.; Herrin, B.R.; Han, B.W.; Turnbough Jr., C.L.; Cooper, M.D.; Wilson, I.A.PDBSumPubMed
3TYGA potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield.9/25/11Pejchal, R.; Huang, P.S.; Schief, W.R.; Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
3TWCA potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield.9/21/11Pejchal, R.; Wilson, I.A.PDBSumPubMed
3TWIVariable Lymphocyte Receptor Recognition of the Immunodominant Glycoprotein of Bacillus anthracis Spores.9/21/11Kirchdoerfer, R.N.; Herrin, B.R.; Han, B.W.; Turnbough Jr., C.L.; Cooper, M.D.; Wilson, I.A.PDBSumPubMed
3TV3A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield.9/19/11Pejchal, R.; Wilson, I.A.PDBSumPubMed
3TCTTafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.8/9/11Connelly, S.; Kelly, J.W.; Wilson, I.A.PDBSumPubMed
3T0VA variable light domain fluorogen activating protein homodimerizes to activate dimethylindole red.7/20/11Stanfield, R.; Senutovitch, N.; Bhattacharyya, S.; Rule, G.; Wilson, I.A.; Armitage, B.; Waggoner, A.S.; Berget, P.PDBSumPubMed
3T0WA variable light domain fluorogen activating protein homodimerizes to activate dimethylindole red.7/20/11Stanfield, R.; Senutovitch, N.; Bhattacharyya, S.; Rule, G.; Wilson, I.A.; Armitage, B.; Waggoner, A.S.; Berget, P.PDBSumPubMed
3T0XA variable light domain fluorogen activating protein homodimerizes to activate dimethylindole red.7/20/11Stanfield, R.; Senutovitch, N.; Bhattacharyya, S.; Rule, G.; Wilson, I.A.; Armitage, B.; Waggoner, A.S.; Berget, P.PDBSumPubMed
3SDYA highly conserved neutralizing epitope on group 2 influenza A viruses.6/9/11Ekiert, D.C.; Wilson, I.A.PDBSumPubMed
3RG1An unusual dimeric structure and assembly for TLR4 regulator RP105-MD-1.4/7/11Yoon, S.I.; Hong, M.; Wilson, I.A.PDBSumPubMed
3R2XComputational design of proteins targeting the conserved stem region of influenza hemagglutinin.3/14/11Ekiert, D.C.; Wilson, I.A.PDBSumPubMed
3R06T cell receptors are structures capable of initiating signaling in the absence of large conformational rearrangements.3/7/11Shore, D.A.; Zhu, X.; Wilson, I.A.PDBSumPubMed
3R08T cell receptors are structures capable of initiating signaling in the absence of large conformational rearrangements.3/7/11Shore, D.A.; Zhu, X.; Wilson, I.A.PDBSumPubMed
3QQBStructural Characterization of an Early Fusion Intermediate of Influenza Virus Hemagglutinin.2/15/11Xu, R.; Wilson, I.A.PDBSumPubMed
3QQEStructural Characterization of an Early Fusion Intermediate of Influenza Virus Hemagglutinin.2/15/11Xu, R.; Wilson, I.A.PDBSumPubMed
3QQIStructural Characterization of an Early Fusion Intermediate of Influenza Virus Hemagglutinin.2/15/11Xu, R.; Wilson, I.A.PDBSumPubMed
3QQOStructural Characterization of an Early Fusion Intermediate of Influenza Virus Hemagglutinin.2/15/11Xu, R.; Wilson, I.A.PDBSumPubMed
3QL0A dynamic knockout reveals that conformational fluctuations influence the chemical step of enzyme catalysis.2/2/11Bhabha, G.; Ekiert, D.C.; Wright, P.E.; Wilson, I.A.PDBSumPubMed
3QL3A dynamic knockout reveals that conformational fluctuations influence the chemical step of enzyme catalysis.2/2/11Bhabha, G.; Ekiert, D.C.; Wright, P.E.; Wilson, I.A.PDBSumPubMed
3QHZAn insertion mutation that distorts antibody binding site architecture enhances function of a human antibody.1/26/11Ekiert, D.C.; Wilson, I.A.PDBSumPubMed
3QHFAn insertion mutation that distorts antibody binding site architecture enhances function of a human antibody.1/25/11Ekiert, D.C.; Wilson, I.A.PDBSumPubMed
3QG6Structural Basis for Ligand Recognition and Discrimination of a Quorum-quenching Antibody.1/24/11Kirchdoerfer, R.N.; Janda, J.D.; Kaufmann, G.F; Wilson, I.APDBSumPubMed
3QG7Structural Basis for Ligand Recognition and Discrimination of a Quorum-quenching Antibody.1/24/11Kirchdoerfer, R.K.; Kaufmann, G.F.; Janda, J.D.; Wilson, I.A.PDBSumPubMed
3Q1SStructure-Based Design of a Protein Immunogen that Displays an HIV-1 gp41 Neutralizing Epitope.12/17/10Stanfield, R.L.; Julien, J.-P.; Pejchal, R.; Gach, J.S.; Zwick, M.B.; Wilson, I.A.PDBSumPubMed
3P3RPotent kinetic stabilizers that prevent transthyretin-mediated cardiomyocyte proteotoxicity.10/5/10Connelly, S.; Wilson, I.A.PDBSumPubMed
3P3SPotent kinetic stabilizers that prevent transthyretin-mediated cardiomyocyte proteotoxicity.10/5/10Connelly, S.; Wilson, I.A.PDBSumPubMed
3P3TPotent kinetic stabilizers that prevent transthyretin-mediated cardiomyocyte proteotoxicity.10/5/10Connelly, S.; Wilson, I.A.PDBSumPubMed
3P3UPotent kinetic stabilizers that prevent transthyretin-mediated cardiomyocyte proteotoxicity.10/5/10Connelly, S.; Wilson, I.A.PDBSumPubMed
3OZ9Crystal Structure of anti-gp41 Fab NC-19/24/10Stanfield, R.L.; Calarese, D.A.; Jiang, S.; Wilson, I.A.PDBSumPubMed
2L25NMR structure of protein NP_888769.1, a phage-related protein in the Bordetella bronchiseptica genome8/11/10Wahab, A.; Serrano, P.; Geralt, M.; Wilson, I.; Wuthrich, K.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
3OAZA nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity.8/6/10Doores, K.J.; Fulton, Z.; Hong, V.; Patel, M.K.; Scanlan, C.N.; Wormald, M.R.; Finn, M.G.; Burton, D.R.; Wilson, I.A.; Davis, B.GPDBSumPubMed
3OB0A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity.8/6/10Doores, K.J.; Fulton, Z.; Hong, V.; Patel, M.K.; Scanlan, C.N.; Wormald, M.R.; Finn, M.G.; Burton, D.R.; Wilson, I.A.; Davis, B.GPDBSumPubMed
2L1SNMR structure of the Klebsiella pneumoniae protein YP_0013362058/5/10Wahab, A.; Serrano, P.; Geralt, M.; Wilson, I.; Wuthrich, K.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
3OAUAntibody 2G12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the HIV-1 glycan shield if domain exchanged.8/5/10Doores, K.J.; Fulton, Z.; Huber, M.; Wilson, I.A.; Burton, D.R.PDBSumPubMed
3OAYA nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity.8/5/10Doores, K.J.; Fulton, Z.; Hong, V.; Patel, M.K.; Scanlan, C.N.; Wormald, M.R.; Finn, M.G.; Burton, D.R.; Wilson, I.A.; Davis, B.GPDBSumPubMed
3O2VCrystal structure of 1E9 PheL89Ser/LeuH47Trp/MetH100bPhe, an engineered Diels-Alderase Fab with modified specificity and catalytic activity7/22/10Verdino, P.; Wilson, I.A.PDBSumPubMed
3O2WCrystal structure of the 1E9 PheL89Ser/LeuH47Trp/MetH100bPhe Fab in complex with a 39A11 transition state analog7/22/10Verdino, P.; Wilson, I.A.PDBSumPubMed
2KZFSolution NMR structure of the thermotoga maritima protein TM08556/16/10Serrano, P.; Jaudzems, K.; Horst, R.; Wilson, I.A.; Wuthrich, K.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
2KZCSolution NMR structure of the protein YP_510488.16/15/10Mohanty, B.; Serrano, P.; Geralt, M.; Horst, R.; Wilson, I.A.; Wuthrich, K.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
2KYZNMR structure of heavy metal binding protein TM0320 from Thermotoga maritima6/9/10Jaudzems, K.; Wahab, A.; Serrano, P.; Geralt, M.; Wuthrich, K.; Wilson, I.A.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
2KYSNMR Structure of the SARS-CoV Nonstructural Protein 7 in Solution at pH 6.5.6/7/10Johnson, M.A.; Jaudzems, K.; Wilson, I.A.; Wuthrich, K.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
3MUGStructure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1.5/3/10Pejchal, R.; Walker, L.M.; Burton, D.R.; Wilson, I.A.PDBSumPubMed
3MUHStructure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1.5/3/10Pejchal, R.; Walker, L.M.; Burton, D.R.; Wilson, I.A.PDBSumPubMed
3MTXCrystal structure of soluble MD-1 and its interaction with lipid IVa.5/1/10Yoon, S.I.; Hong, M.; Han, G.W.; Wilson, I.A.PDBSumPubMed
3MU3Crystal structure of soluble MD-1 and its interaction with lipid IVa.5/1/10Yoon, S.I.; Hong, M.; Han, G.W.; Wilson, I.A.PDBSumPubMed
3MJ6The molecular interaction of CAR and JAML recruits the central cell signal transducer PI3K.4/12/10Verdino, P.; Wilson, I.A.PDBSumPubMed
3MJ7The molecular interaction of CAR and JAML recruits the central cell signal transducer PI3K.4/12/10Verdino, P.; Wilson, I.A.PDBSumPubMed
3MJ8cDNA sequence and Fab crystal structure of HL4E10, a hamster IgG lambda light chain antibody stimulatory for gammadelta T cells.4/12/10Verdino, P.; Wilson, I.A.PDBSumPubMed
3MJ9Molecular insights into gamma delta T cell costimulation by an anti-JAML antibody.4/12/10Verdino, P.; Wilson, I.A.PDBSumPubMed
3MBEThe diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinity.3/25/10Corper, A.L.; Yoshida, K.; Teyton, L.; Wilson I.A.PDBSumPubMed
3LZFStructural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.3/1/10Ekiert, D.C.; Wilson, I.A.PDBSumPubMed
3LZGStructural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.3/1/10Xu, R.; Wilson, I.A.PDBSumPubMed
2KTSNMR structure of the protein NP_415897.12/6/10Serrano, P.; Jaudzems, K.; Geralt, M.; Horst, R.; Wuthrich, K.; Wilson, I.A.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
3L4BCrystal Structure of an Octomeric Two-Subunit TrkA K+ Channel Ring Gating Assembly, TM1088A:TM1088B, from Thermotoga maritima12/18/09Deller, M.C.; Johnson, H.A.; Miller, M.; Spraggon, G.; Wilson, I.A.; Lesley, S.A.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
3KU3Structure, receptor binding, and antigenicity of influenza virus hemagglutinins from the 1957 H2N2 pandemic.11/26/09Xu, R.; Wilson, I.A.PDBSumPubMed
3KU5Structure, receptor binding, and antigenicity of influenza virus hemagglutinins from the 1957 H2N2 pandemic.11/26/09Xu, R.; Wilson, I.A.PDBSumPubMed
3KU6Structure, receptor binding, and antigenicity of influenza virus hemagglutinins from the 1957 H2N2 pandemic.11/26/09Xu, R.; Wilson, I.A.PDBSumPubMed
3JXOCrystal Structure of an Octomeric Two-Subunit TrkA K+ Channel Ring Gating Assembly, TM1088A:TM1088B, from Thermotoga maritima9/20/09Deller, M.C.; Johnson, H.A.; Miller, M.; Spraggon, G.; Wilson, I.A.; Lesley, S.A.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
3IMRA substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity.8/11/09Connelly, S.; Wilson, I.A.PDBSumPubMed
3IMSA substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity.8/11/09Connelly, S.; Wilson, I.A.PDBSumPubMed
3IMTA substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity.8/11/09Connelly, S.; Wilson, I.PDBSumPubMed
3IMUA substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity.8/11/09Connelly, S.; Wilson, I.A.PDBSumPubMed
3IMVA substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity.8/11/09Connelly, S.; Wilson, I.A.PDBSumPubMed
3IMWA substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity.8/11/09Connelly, S.; Wilson, I.A.PDBSumPubMed
2KL2Comparison of NMR and crystal structures highlights conformational isomerism in protein active sites.6/30/09Pedrini, B.; Serrano, P.; Mohanty, B.; Geralt, M.; Herrmann, T.; Wuthrich, K.; Wilson, I.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
2KL4Solution structure of the protein NB7804A from Bacillus Halodurans6/30/09Mohanty, B.; Geralt, M.; Augustyniak, W.; Serrano, P.; Horst, R.; Wilson, I.A.; Wuthrich, K.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
2KLANMR structure of the protein NP_247299.1: comparison with the crystal structure.6/30/09Jaudzems, K.; Mohanty, B.; Geralt, M.; Serrano, P.; Wilson, I.; Wuthrich, K.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
3HJ0Chemoselective small molecules that covalently modify one lysine in a non-enzyme protein in plasma.5/20/09Connelly, S.; Wilson, I.A.; Kelly, J.W.PDBSumPubMed
3GRLStructural and functional analysis of the globular head domain of p115 provides insight into membrane tethering.3/25/09An, Y.; Elsliger, M.A.; Wilson, I.A.PDBSumPubMed
3GQ2Structural and functional analysis of the globular head domain of p115 provides insight into membrane tethering.3/23/09An, Y.; Elsliger, M.A.; Wilson, I.A.PDBSumPubMed
3GMLStructural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.3/14/09Schiefner, A.; Wilson, I.A.PDBSumPubMed
3GMMStructural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.3/14/09Schiefner, A.; Wilson, I.A.PDBSumPubMed
3GMNStructural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.3/14/09Schiefner, A.; Wilson, I.A.PDBSumPubMed
3GMOStructural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.3/14/09Schiefner, A.; Wilson, I.A.PDBSumPubMed
3GMPStructural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.3/14/09Schiefner, A.; Wilson, I.A.PDBSumPubMed
3GMQStructural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.3/14/09Schiefner, A.; Wilson, I.A.PDBSumPubMed
3GMRStructural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.3/14/09Schiefner, A.; Wilson, I.A.PDBSumPubMed
3GBMAntibody recognition of a highly conserved influenza virus epitope.2/20/09Ekiert, D.C.; Elsliger, M.A.; Wilson, I.A.PDBSumPubMed
3GBNAntibody recognition of a highly conserved influenza virus epitope.2/20/09Ekiert, D.C.; Elsliger, M.A.; Wilson, I.A.PDBSumPubMed
3FO9Direct observation of an enamine intermediate in amine catalysis12/29/08Zhu, X.; Wilson, I.A.PDBSumPubMed
3FO0An aspartate and a water molecule mediate efficient acid-base catalysis in a tailored antibody pocket.12/27/08Debler, E.W.; Wilson, I.A.PDBSumPubMed
3FO1An aspartate and a water molecule mediate efficient acid-base catalysis in a tailored antibody pocket.12/27/08Debler, E.W.; Wilson, I.A.PDBSumPubMed
3FO2An aspartate and a water molecule mediate efficient acid-base catalysis in a tailored antibody pocket.12/27/08Debler, E.W.; Wilson, I.A.PDBSumPubMed
3FN0A conformational switch in human immunodeficiency virus gp41 revealed by the structures of overlapping epitopes recognized by neutralizing antibodies.12/22/08Pejchal, R.; Wilson, I.A.; Zwick, M.B.PDBSumPubMed
2KAFSARS coronavirus unique domain: three-domain molecular architecture in solution and RNA binding.11/5/08Johnson, M.A.; Mohanty, B.; Pedrini, B.; Serrano, P.; Chatterjee, A.; Herrmann, T.; Joseph, J.; Saikatendu, K.; Wilson, I.A.; Buchmeier, M.J.; Kuhn, P.; Wuthrich, K.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
2KA7The J-UNIO protocol for automated protein structure determination by NMR in solution.10/31/08Pedrini, B.; Herrmann, T.; Mohanty, B.; Geralt, M.; Wilson, I.; Wuthrich, K.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
2KA5Comparison of NMR and crystal structures highlights conformational isomerism in protein active sites.10/30/08Serrano, P.; Geralt, M.; Mohanty, B.; Pedrini, B.; Horst, R.; Wuthrich, K.; Wilson, I.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
2K9ZComparison of NMR and crystal structures for the proteins TM1112 and TM1367.10/28/08Mohanty, B.; Pedrini, B.; Serrano, P.; Geralt, M.; Horst, R.; Herrmann, T.; Wilson, I.A.; Wuthrich, K.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
2KA0Comparison of NMR and crystal structures for the proteins TM1112 and TM1367.10/27/08Mohanty, B.; Pedrini, B.; Serrano, P.; Geralt, M.; Horst, R.; Herrmann, T.; Wilson, I.A.; Wuthrich, K.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
3ESNToward optimization of the second aryl substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies.10/6/08Connelly, S.; Wilson, I.A.PDBSumPubMed
3ESOToward optimization of the second aryl substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies.10/6/08Connelly, S.; Wilson, I.A.PDBSumPubMed
3ESPToward optimization of the second aryl substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies.10/6/08Connelly, S.; Wilson, I.A.PDBSumPubMed
2K87Nuclear magnetic resonance structure of the nucleic acid-binding domain of severe acute respiratory syndrome coronavirus nonstructural protein 3.9/2/08Serrano, P.; Wuthrich, K.; Johnson, M.A.; Chatterjee, A.; Wilson, I.; Pedrini, B.F.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
3E6JAntigen recognition by variable lymphocyte receptors.8/15/08Han, B.W.; Herrin, B.R.; Cooper, M.D.; Wilson, I.A.PDBSumPubMed
3DBXThe crystal structure of avian CD1 reveals a smaller, more primordial antigen-binding pocket compared to mammalian CD16/2/08Zajonc, D.M.; Wilson, I.A.PDBSumPubMed
3CYEStructure determination of the 1918 H1N1 neuraminidase from a crystal with lattice-translocation defects4/25/08Zhu, X.; Xu, X.; Wilson, I.A.PDBSumPubMed
3CUPCrystal structure of the MHC class II molecule I-Ag7 in complex with the peptide GAD221-2354/16/08Corper, A.L.; Yoshida, K.; Teyton, L.; Wilson, I.A.PDBSumPubMed
3CN0Toward optimization of the linker substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies.3/24/08Connelly, S.; Wilson, I.A.PDBSumPubMed
3CN1Toward optimization of the linker substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies.3/24/08Connelly, S.; Wilson, I.A.PDBSumPubMed
3CN2Toward optimization of the linker substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies.3/24/08Connelly, S.; Wilson, I.A.PDBSumPubMed
3CN3Toward optimization of the linker substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies.3/24/08Connelly, S.; Wilson, I.A.PDBSumPubMed
3CN4Toward optimization of the linker substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies.3/24/08Connelly, S.; Wilson, I.A.PDBSumPubMed
3CFJConformational isomerism can limit antibody catalysis.3/4/08Debler, E.W.; Wilson, I.A.PDBSumPubMed
3CFKConformational isomerism can limit antibody catalysis.3/4/08Debler, E.W.; Wilson, I.A.PDBSumPubMed
3CFBDeeply inverted electron-hole recombination in a luminescent antibody-stilbene complex.3/3/08Debler, E.W.; Wilson, I.A.PDBSumPubMed
3CFCDeeply inverted electron-hole recombination in a luminescent antibody-stilbene complex.3/3/08Debler, E.W.; Wilson, I.A.PDBSumPubMed
3CFDDeeply inverted electron-hole recombination in a luminescent antibody-stilbene complex.3/3/08Debler, E.W.; Heine, A.; Wilson, I.A.PDBSumPubMed
3CFEDeeply inverted electron-hole recombination in a luminescent antibody-stilbene complex.3/3/08Debler, E.W.; Heine, A.; Wilson, I.A.PDBSumPubMed
3C2AStructure determination of an anti-HIV-1 Fab 447-52D-peptide complex from an epitaxially twinned data set1/24/08Dhillon, A.K.; Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
2RNKNuclear magnetic resonance structure shows that the severe acute respiratory syndrome coronavirus-unique domain contains a macrodomain fold.1/11/08Chatterjee, A.; Johnson, M.A.; Serrano, P.; Pedrini, B.; Joseph, J.; Saikatendu, K.; Neuman, B.W.; Wilson, I.A.; Stevens, R.C.; Buchmeier, M.J.; Kuhn, P.; Wuthrich, K.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
2JZDNuclear magnetic resonance structure shows that the severe acute respiratory syndrome coronavirus-unique domain contains a macrodomain fold.1/4/08Chatterjee, A.; Johnson, M.A.; Serrano, P.; Pedrini, B.; Joseph, J.; Saikatendu, K.; Neuman, B.; Stevens, R.C.; Wilson, I.A.; Buchmeier, M.J.; Kuhn, P.; Wuthrich, K.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
2JZENuclear magnetic resonance structure shows that the severe acute respiratory syndrome coronavirus-unique domain contains a macrodomain fold.1/4/08Chatterjee, A.; Johnson, M.A.; Serrano, P.; Pedrini, B.; Joseph, J.; Saikatendu, K.; Neuman, B.; Stevens, R.C.; Wilson, I.A.; Buchmeier, M.J.; Kuhn, P.; Wuthrich, K.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
2JZFNuclear magnetic resonance structure shows that the severe acute respiratory syndrome coronavirus-unique domain contains a macrodomain fold.1/4/08Chatterjee, A.; Johnson, M.A.; Serrano, P.; Pedrini, B.; Joseph, J.; Saikatendu, K.; Neuman, B.; Stevens, R.C.; Wilson, I.A.; Buchmeier, M.J.; Kuhn, P.; Wuthrich, K.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
3BEQStructural characterization of the 1918 influenza virus H1N1 neuraminidase11/19/07Xu, X.; Zhu, X.; Wilson, I.A.PDBSumPubMed
3B9KThe Crystal Structure of CD8 in Complex with YTS156.7.7 Fab and Interaction with Other CD8 Antibodies Define the Binding Mode of CD8 alphabeta to MHC Class I11/5/07Shore, D.; Wilson, I.A.PDBSumPubMed
3B7EStructural characterization of the 1918 influenza virus H1N1 neuraminidase10/30/07Xu, X.; Zhu, X.; Wilson, I.A.PDBSumPubMed
2R9UCrystal Structure of Lamprey Variable Lymphocyte Receptor 2913 Ectodomain.9/13/07Han, B.W.; Herrin, B.R.; Choe, J.; Cooper, M.D.; Wilson, I.A.PDBSumPubMed
2R6QCrystal structure of BclA-island Construct9/6/07Han, B.W.; Herrin, B.R.; Turnbough Jr., C.L.; Cooper, M.D.; Wilson, I.A.PDBSumPubMed
2QSCStructure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization.7/30/07Bell, C.H.; Schiefner, A.; Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
2QGBBiochemical and structural evaluation of highly selective 2-arylbenzoxazole-based transthyretin amyloidogenesis inhibitors.6/28/07Connelly, S.; Wilson, I.A.PDBSumPubMed
2QGCBiochemical and structural evaluation of highly selective 2-arylbenzoxazole-based transthyretin amyloidogenesis inhibitors.6/28/07Connelly, S.; Wilson, I.A.PDBSumPubMed
2QGDBiochemical and structural evaluation of highly selective 2-arylbenzoxazole-based transthyretin amyloidogenesis inhibitors.6/28/07Connelly, S.; Wilson, I.A.PDBSumPubMed
2QGEBiochemical and structural evaluation of highly selective 2-arylbenzoxazole-based transthyretin amyloidogenesis inhibitors.6/28/07Connelly, S.; Wilson, I.A.PDBSumPubMed
2Q7YCrystal Structures of Mouse CD1d-iGb3 Complex and its Cognate Valpha14 T Cell Receptor Suggest a Model for Dual Recognition of Foreign and Self Glycolipids.6/7/07Zajonc, D.M.; Wilson, I.A.; Teyton, L.PDBSumPubMed
2PRTStructure of the Wilms tumor suppressor protein zinc finger domain bound to DNA5/4/07Stoll, R.; Lee, B.M.; Debler, E.W.; Laity, J.H.; Wilson, I.A.; Dyson, H.J.; Wright, P.E.PDBSumPubMed
2JPAStructure of the wilms tumor suppressor protein zinc finger domain bound to DNA5/1/07Stoll, R.; Lee, B.M.; Debler, E.W.; Laity, J.H.; Wilson, I.A.; Dyson, H.J.; Wright, P.E.PDBSumPubMed
2JP9Structure of the wilms tumor suppressor protein zinc finger domain bound to DNA4/30/07Stoll, R.; Lee, B.M.; Debler, E.W.; Laity, J.H.; Wilson, I.A.; Dyson, H.J.; Wright, P.E.PDBSumPubMed
2OQJA peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120.1/31/07Calarese, D.A.; Stanfield, R.L.; Menendez, A.; Scott, J.K.; Wilson, I.A.PDBSumPubMed
2OP4Crystal Structures of a Quorum-quenching Antibody.1/26/07Kirchdoerfer, R.N.; Debler, E.W.; Wilson, I.A.PDBSumPubMed
2OJZSpecific recognition of a DNA immunogen by its elicited antibody1/15/07Stanfield, R.L.; Sanguineti, S.; Wilson, I.A.; de Prat-Gay, G.PDBSumPubMed
2OK0Specific recognition of a DNA immunogen by its elicited antibody1/15/07Stanfield, R.L.; Sanguineti, S.; Wilson, I.A.; de Prat-Gay, G.PDBSumPubMed
2O5XClosely related antibody receptors exploit fundamentally different strategies for steroid recognition.12/6/06Verdino, P.; Wilson, I.A.PDBSumPubMed
2O5YClosely related antibody receptors exploit fundamentally different strategies for steroid recognition.12/6/06Verdino, P.; Wilson, I.A.PDBSumPubMed
2O5ZClosely related antibody receptors exploit fundamentally different strategies for steroid recognition.12/6/06Verdino, P.; Wilson, I.A.PDBSumPubMed
2NTFCrystal Structures of a Quorum-quenching Antibody.11/7/06Debler, E.W.; Wilson, I.A.PDBSumPubMed
2I24Maturation of Shark Single-domain (IgNAR) Antibodies: Evidence for Induced-fit Binding8/15/06Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
2I25Maturation of Shark Single-domain (IgNAR) Antibodies: Evidence for Induced-fit Binding8/15/06Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
2I26Maturation of Shark Single-domain (IgNAR) Antibodies: Evidence for Induced-fit Binding.8/15/06Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
2I27Maturation of Shark Single-domain (IgNAR) Antibodies: Evidence for Induced-fit Binding.8/15/06Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
2HSXNovel beta-barrel fold in the nuclear magnetic resonance structure of the replicase nonstructural protein 1 from the severe acute respiratory syndrome coronavirus.7/24/06Almeida, M.S.; Herrmann, T.; Geralt, M.; Johnson, M.A.; Saikatendu, K.; Joseph, J.; Subramanian, R.C.; Neuman, B.W.; Buchmeier, M.J.; Stevens, R.C.; Kuhn, P.; Wilson, I.A.; Wuthrich, K.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
2IU3Structure-Based Design, Synthesis, Evaluation, and Crystal Structures of Transition State Analogue Inhibitors of Inosine Monophosphate Cyclohydrolase5/27/06Xu, L.; Chong, Y.; Hwang, I.; D'Onofrio, A.; Amore, K.; Beardsley, G.P.; Li, C.; Olson, A.J.; Boger, D.L.; Wilson, I.A.PDBSumPubMed
2IU0Structure-Based Design, Synthesis, Evaluation, and Crystal Structures of Transition State Analogue Inhibitors of Inosine Monophosphate Cyclohydrolase5/26/06Xu, L.; Chong, Y.; Hwang, I.; Onofrio, A.D.; Amore, K.; Beardsley, G.P.; Li, C.; Olson, A.J.; Boger, D.L.; Wilson, I.A.PDBSumPubMed
2GJZBifunctional Catalysis of Proton Transfer at an Antibody Active Site.3/31/06Debler, E.W.; Wilson, I.A.PDBSumPubMed
2GK0Bifunctional Catalysis of Proton Transfer at an Antibody Active Site.3/31/06Debler, E.W.; Wilson, I.A.PDBSumPubMed
2GDTNovel beta-barrel fold in the nuclear magnetic resonance structure of the replicase nonstructural protein 1 from the severe acute respiratory syndrome coronavirus.3/17/06Almeida, M.S.; Herrmann, T.; Geralt, M.; Johnson, M.A.; Saikatendu, K.; Joseph, J.; Subramanian, R.C.; Neuman, B.W.; Buchmeier, M.J.; Stevens, R.C.; Kuhn, P.; Wilson, I.A.; Wuthrich, K.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
2G2RThe Effects of Antibodies on Stilbene Excited-State Energetics.2/16/06Debler, E.W.; Wilson, I.A.PDBSumPubMed
2FX7Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10.2/3/06Cardoso, R.M.F.; Brunel, F.M.; Ferguson, S.; Burton, D.R.; Dawson, P.E.; Wilson, I.A.PDBSumPubMed
2FX8Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10.2/3/06Cardoso, R.M.F.; Brunel, F.M.; Ferguson, S.; Burton, D.R.; Dawson, P.E.; Wilson, I.A.PDBSumPubMed
2FX9Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10.2/3/06Cardoso, R.M.F.; Brunel, F.M.; Ferguson, S.; Burton, D.R.; Dawson, P.E.; Wilson, I.A.PDBSumPubMed
2FL5Cofactor-containing antibodies: Crystal structure of the original yellow antibody.1/5/06Zhu, X.; Wilson, I.A.PDBSumPubMed
2FK0Structure and Receptor Specificity of the Hemagglutinin from an H5N1 Influenza Virus.1/3/06Stevens, J.; Wilson, I.A.PDBSumPubMed
2ERJCrystal structure of the IL-2 signaling complex: Paradigm for a heterotrimeric cytokine receptor.10/25/05Debler, E.W.; Stauber, D.J.; Wilson, I.A.PDBSumPubMed
2B4CStructure of a V3-containing HIV-1 gp120 core.9/23/05Huang, C.; Tang, M.; Zhang, M.Y.; Majeed, S.; Montabana, E.; Stanfield, R.L.; Dimitrov, D.S.; Korber, B.; Sodroski, J.; Wilson, I.A.; Wyatt, R.; Kwong, P.D.PDBSumPubMed
2B1ACrystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity.9/15/05Stanfield, R.L.; Gorny, M.K.; Zolla-Pazner, S.; Wilson, I.A.PDBSumPubMed
2B1GStructure-based Design, Synthesis, Evaluation, and Crystal Structures of Transition State Analogue Inhibitors of Inosine Monophosphate Cyclohydrolase.9/15/05Xu, L.; Chong, Y.; Hwang, I.; D'Onofrio, A.; Amore, K.; Beardsley, G.P.; Li, C.; Olson, A.J.; Boger, D.L.; Wilson, I.A.PDBSumPubMed
2B1HCrystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity.9/15/05Stanfield, R.L.; Gorny, M.K.; Zolla-Pazner, S.; Wilson, I.A.PDBSumPubMed
2B1IStructure-based Design, Synthesis, Evaluation, and Crystal Structures of Transition State Analogue Inhibitors of Inosine Monophosphate Cyclohydrolase.9/15/05Xu, L.; Chong, Y.; Hwang, I.; D'Onofrio, A.; Amore, K.; Beardsley, G.P.; Li, C.; Olson, A.J.; Boger, D.L.; Wilson, I.A.PDBSumPubMed
2B0SCrystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity.9/14/05Stanfield, R.L.; Gorny, M.K.; Zolla-Pazner, S.; Wilson, I.A.PDBSumPubMed
2ARJCrystal structure of the TCR co-receptor CD8alphaalpha in complex with monoclonal antibody YTS 105.18 Fab fragment at 2.88 A resolution.8/19/05Shore, D.A.; Teyton, L.; Dwek, R.A.; Rudd, P.M.; Wilson, I.A.PDBSumPubMed
2AKRStructural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity8/3/05Zajonc, D.M.; Halder, R.; Wu, D.; Maricic, I.; Roy, K.; Wong, C.-H.; Kumar, V.; Wilson, I.A.PDBSumPubMed
2AJSComplete reaction cycle of a cocaine catalytic antibody at atomic resolution.8/2/05Zhu, X.; Wilson, I.A.PDBSumPubMed
2AJUComplete reaction cycle of a cocaine catalytic antibody at atomic resolution.8/2/05Zhu, X.; Wilson, I.A.PDBSumPubMed
2AJVComplete reaction cycle of a cocaine catalytic antibody at atomic resolution.8/2/05Zhu, X.; Wilson, I.A.PDBSumPubMed
2AJXComplete reaction cycle of a cocaine catalytic antibody at atomic resolution.8/2/05Zhu, X.; Wilson, I.A.PDBSumPubMed
2AJYComplete reaction cycle of a cocaine catalytic antibody at atomic resolution.8/2/05Zhu, X.; Wilson, I.A.PDBSumPubMed
2AJZComplete reaction cycle of a cocaine catalytic antibody at atomic resolution.8/2/05Zhu, X.; Wilson, I.A.PDBSumPubMed
2AK1Complete reaction cycle of a cocaine catalytic antibody at atomic resolution.8/2/05Zhu, X.; Wilson, I.A.PDBSumPubMed
2AFDSolution structure of Asl1650, an acyl carrier protein from Anabaena sp. PCC 7120 with a variant phosphopantetheinylation-site sequence7/25/05Johnson, M.A.; Peti, W.; Herrmann, T.; Wilson, I.A.; Wuthrich, K.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
2AFESolution structure of Asl1650, an acyl carrier protein from Anabaena sp. PCC 7120 with a variant phosphopantetheinylation-site sequence7/25/05Johnson, M.A.; Peti, W.; Herrmann, T.; Wilson, I.A.; Wuthrich, K.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
1ZXTCrystal structure of viral macrophage inflammatory protein I encoded by Kaposi's sarcoma-associated herpesvirus at 1.7A.6/8/05Luz, J.G.; Yu, M.; Su, Y.; Wu, Z.; Zhou, Z.; Sun, R.; Wilson, I.A.PDBSumPubMed
1ZLSDissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G125/9/05Calarese, D.A.; Lee, H.-K.; Best, M.D.; Astronomo, R.D.; Stanfield, R.L.; Burton, D.R.; Wong, C.H.; Wilson, I.A.PDBSumPubMed
1ZLUDissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G125/9/05Calarese, D.A.; Lee, H.-K.; Best, M.D.; Astronomo, R.D.; Stanfield, R.L.; Burton, D.R.; Wong, C.H.; Wilson, I.A.PDBSumPubMed
1ZLVDissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G125/9/05Calarese, D.A.; Lee, H.-K.; Best, M.D.; Astronomo, R.D.; Stanfield, R.L.; Burton, D.R.; Wong, C.H.; Wilson, I.A.PDBSumPubMed
1ZLWDissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G125/9/05Calarese, D.A.; Lee, H.-K.; Best, M.D.; Astronomo, R.D.; Stanfield, R.L.; Burton, D.R.; Wong, C.H.; Wilson, I.A.PDBSumPubMed
1ZIWCrystal structure of human toll-like receptor 3 (TLR3) ectodomain.4/27/05Wilson, I.A.; Choe, J.PDBSumPubMed
1ZHNCrystal structure of mouse CD1d bound to the self ligand phosphatidylcholine: a molecular basis for NKT cell activation4/26/05Giabbai, B.; Sidobre, S.; Crispin, M.M.D.; Sanchez Ruiz, Y.; Bachi, A.; Kronenberg, M.; Wilson, I.A.; Degano, M.PDBSumPubMed
1Z5LStructure and function of a potent agonist for the semi-invariant natural killer T cell receptor.3/18/05Zajonc, D.M.; Cantu, C.; Mattner, J.; Zhou, D.; Savage, P.B.; Bendelac, A.; Wilson, I.A.; Teyton, L.PDBSumPubMed
1Y18Structural origins of efficient proton abstraction from carbon by a catalytic antibody11/17/04Debler, E.W.; Ito, S.; Heine, A.; Wilson, I.A.PDBSumPubMed
1Y0LStructural origins of efficient proton abstraction from carbon by a catalytic antibody11/15/04Debler, E.W.; Ito, S.; Heine, A.; Wilson, I.A.PDBSumPubMed
1XZ0Molecular Mechanism of Lipopeptide Presentation by CD1a.11/11/04Zajonc, D.M.; Crispin, M.D.; Bowden, T.A.; Young, D.C.; Cheng, T.Y.; Hu, J.; Costello, C.E.; Miller, M.J.; Moody, D.B.; Wilson, I.A.PDBSumPubMed
1U9KCrystal Structure of Mouse Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) at 1.76A8/9/04Kelker, M.S.; Debler, E.W.; Wilson, I.A.PDBSumPubMed
1U7XCrystal structures of apo wild-type M. jannaschii tyrosyl-tRNA synthetase (TyrRS) and an engineered TyrRS specific for O-methyl-L-tyrosine.8/4/04Zhang, Y.; Wang, L.; Schultz, P.G.; Wilson, I.A.PDBSumPubMed
1U7DCrystal structures of apo wild-type M. jannaschii tyrosyl-tRNA synthetase (TyrRS) and an engineered TyrRS specific for O-methyl-L-tyrosine.8/3/04Zhang, Y.; Wang, L.; Schultz, P.G.; Wilson, I.A.PDBSumPubMed
1U21Kinetic stabilization of an oligomeric protein by a single ligand binding event7/16/04Wiseman, R.L.; Johnson, S.M.; Kelker, M.S.; Foss, T.; Wilson, I.A.; Kelly, J.W.PDBSumPubMed
1TZGBroadly Neutralizing Anti-HIV Antibody 4E10 Recognizes a Helical Conformation of a Highly Conserved Fusion-Associated Motif in gp417/9/04Cardoso, R.M.F.; Zwick, M.B.; Stanfield, R.L.; Kunert, R.; Binley, J.M.; Katinger, H.; Burton, D.R.; Wilson, I.A.PDBSumPubMed
1THZCrystal structure of avian aminoimidazole-4-carboxamide ribonucleotide transformylase in complex with a novel non-folate inhibitor identified by virtual ligand screening.6/1/04Xu, L.; Li, C.; Olson, A.J.; Wilson, I.A.PDBSumPubMed
1T6VCrystal structure of a shark single-domain antibody V region in complex with lysozyme.5/7/04Stanfield, R.L.; Dooley, H.; Flajnik, M.F.; Wilson, I.A.PDBSumPubMed
1T4KThe Origin of Enantioselectivity in Aldolase Antibodies: Crystal Structure, Site-directed Mutagenesis, and Computational Analysis4/29/04Zhu, X.; Wilson, I.A.PDBSumPubMed
1SXRCrystal structure of the Drosophila peptidoglycan recognition protein (PGRP)-SA at 1.56 A resolution3/31/04Reiser, J.B.; Teyton, L.; Wilson, I.A.PDBSumPubMed
1SQ2Crystal structure of a shark single-domain antibody V region in complex with lysozyme.3/17/04Stanfield, R.L.; Dooley, H.; Flajnik, M.F.; Wilson, I.A.PDBSumPubMed
1SMOCrystal Structure of Human Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) at 1.47A.3/9/04Kelker, M.S.; Foss, T.R.; Peti, W.; Teyton, L.; Kelly, J.W.; Wilson, I.A.PDBSumPubMed
1SJ5On the use of DXMS to produce more crystallizable proteins: structures of the T. maritima proteins TM0160 and TM1171.3/2/04Spraggon, G.; Panatazatos, D.; Klock, H.E.; Wilson, I.A.; Woods Jr., V.L.; Lesley, S.A.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
1RU9Probing the antibody-catalyzed water-oxidation pathway at atomic resolution.12/11/03Zhu, X.; Wentworth Jr., P.; Wentworth, A.D.; Eschenmoser, A.; Lerner, R.A.; Wilson, I.A.PDBSumPubMed
1RUAProbing the antibody-catalyzed water-oxidation pathway at atomic resolution.12/11/03Zhu, X.; Wentworth Jr., P.; Wentworth, A.D.; Eschenmoser, A.; Lerner, R.A.; Wilson, I.A.PDBSumPubMed
1RUKProbing the antibody-catalyzed water-oxidation pathway at atomic resolution.12/11/03Zhu, X.; Wentworth Jr., P.; Wentworth, A.D.; Eschenmoser, A.; Lerner, R.A.; Wilson, I.A.PDBSumPubMed
1RULProbing the antibody-catalyzed water-oxidation pathway at atomic resolution.12/11/03Zhu, X.; Wentworth Jr., P.; Wentworth, A.D.; Eschenmoser, A.; Lerner, R.A.; Wilson, I.A.PDBSumPubMed
1RUMProbing the antibody-catalyzed water-oxidation pathway at atomic resolution.12/11/03Zhu, X.; Wentworth Jr., P.; Wentworth, A.D.; Eschenmoser, A.; Lerner, R.A.; Wilson, I.A.PDBSumPubMed
1RUPProbing the antibody-catalyzed water-oxidation pathway at atomic resolution.12/11/03Zhu, X.; Wentworth Jr., P.; Wentworth, A.D.; Eschenmoser, A.; Lerner, R.A.; Wilson, I.A.PDBSumPubMed
1RUQProbing the antibody-catalyzed water-oxidation pathway at atomic resolution.12/11/03Zhu, X.; Wentworth Jr., P.; Wentworth, A.D.; Eschenmoser, A.; Lerner, R.A.; Wilson, I.A.PDBSumPubMed
1RURProbing the antibody-catalyzed water-oxidation pathway at atomic resolution.12/11/03Zhu, X.; Wentworth Jr., P.; Wentworth, A.D.; Eschenmoser, A.; Lerner, R.A.; Wilson, I.A.PDBSumPubMed
1RD8Structure of the Uncleaved Human H1 Hemagglutinin from the Extinct 1918 Influenza Virus.11/5/03Stevens, J.; Corper, A.L.; Basler, C.F.; Taubenberger, J.K.; Palese, P.; Wilson, I.A.PDBSumPubMed
1RBMHuman GAR Tfase complex structure11/3/03Zhang, Y.; Desharnais, J.; Boger, D.L.; Wilson, I.A.PDBSumPubMed
1RBQHuman GAR Tfase complex structure with polyglutamated 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrofolic acid11/3/03Zhang, Y.; Desharnais, J.; Boger, D.L.; Wilson, I.A.PDBSumPubMed
1RBYHuman GAR Tfase complex structure11/3/03Zhang, Y.; Desharnais, J.; Boger, D.L.; Wilson, I.A.PDBSumPubMed
1RBZHuman GAR Tfase complex structure11/3/03Zhang, Y.; Desharnais, J.; Boger, D.L.; Wilson, I.A.PDBSumPubMed
1RC0Human GAR Tfase complex structure11/3/03Zhang, Y.; Desharnais, J.; Boger, D.L.; Wilson, I.A.PDBSumPubMed
1RC1Human GAR Tfase complex structure11/3/03Zhang, Y.; Desharnais, J.; Boger, D.L.; Wilson, I.A.PDBSumPubMed
1R3HCombined pseudo-merohedral twinning, non-crystallographic symmetry and pseudo-translation in a monoclinic crystal form of the gammadelta T-cell ligand T10.10/2/03Rudolph, M.G.; Wilson, I.A.PDBSumPubMed
1QWHKinetic stabilization of the native state by protein engineering: implications for inhibition of transthyretin amyloidogenesis.9/2/03Foss, T.; Kelker, M.S.; Wilson, I.A.PDBSumPubMed
1Q1JStructural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D.7/21/03Stanfield, R.L.; Gorny, M.K.; Williams, C.; Zolla-Pazner, S.; Wilson, I.A.PDBSumPubMed
1PKXStructural Insights into the Human and Avian IMP Cyclohydrolase Mechanism via Crystal Structures with the Bound XMP Inhibitor.6/6/03Wolan, D.W.; Cheong, C.G.; Greasley, S.E.; Wilson, I.A.PDBSumPubMed
1PL0Crystal Structures of Human Bifunctional Enzyme Aminoimidazole-4-carboxamide Ribonucleotide Transformylase/IMP Cyclohydrolase in Complex with Potent Sulfonyl-containing Antifolates.6/6/03Cheong, C.G.; Greasley, S.E.; Horton, P.A.; Beardsley, G.P.; Wilson, I.A.PDBSumPubMed
1P4RCrystal structures of human bifunctional enzyme aminoimidazole-4-carboxamide ribonucleotide transformylase/IMP cyclohydrolase in complex with potent sulfonyl-containing antifolates4/23/03Cheong, C.-G.; Greasley, S.E.; Horton, P.A.; Beardsley, G.P.; Wilson, I.A.PDBSumPubMed
1P1XAnalysis of the class I aldolase binding site architecture based on the crystal structure of 2-deoxyribose-5-phosphate aldolase at 0.99A resolution.4/14/03Heine, A.; Luz, J.G.; Wong, C.H.; Wilson, I.A.PDBSumPubMed
1OZ0Structure of Avian AICAR Transformylase with a Multisubstrate Adduct Inhibitor beta-DADF Identifies the Folate Binding Site.4/7/03Wolan, D.W.; Greasley, S.E.; Wall, M.J.; Benkovic, S.J.; Wilson, I.A.PDBSumPubMed
1OP3Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.3/4/03Calarese, D.A.; Scanlan, C.N.; Zwick, M.B.; Deechongkit, S.; Mimura, Y.; Kunert, R.; Stanfield, R.L.; Kelly, J.W.; Rudd, P.M.; Dwek, R.A.; Katinger, H.; Burton, D.R.; Wilson, I.A.PDBSumPubMed
1OP5Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.3/4/03Calarese, D.A.; Scanlan, C.N.; Zwick, M.B.; Deechongkit, S.; Mimura, Y.; Kunert, R.; Stanfield, R.L.; Kelly, J.W.; Rudd, P.M.; Dwek, R.A.; Katinger, H.; Burton, D.R.; Wilson, I.A.PDBSumPubMed
1ONQCrystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 A.2/28/03Zajonc, D.M.; Elsliger, M.A.; Teyton, L.; Wilson, I.A.PDBSumPubMed
1OM3Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.2/24/03Calarese, D.A.; Scanlan, C.N.; Zwick, M.B.; Deechongkit, S.; Mimura, Y.; Kunert, R.; Stanfield, R.L.; Kelly, J.W.; Rudd, P.M.; Dwek, R.A.; Katinger, H.; Burton, D.R.; Wilson, I.A.PDBSumPubMed
1NJSRational Design, Synthesis, Evaluation, and Crystal Structure of a Potent Inhibitor of Human GAR Tfase: 10-(Trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrofolic Acid1/2/03Zhang, Y.; Desharnais, J.; Marsilje, T.H.; Li, C.; Hedrick, M.P.; Gooljarsingh, L.T.; Tavassoli, A.; Benkovic, S.J.; Olson, A.J.; Boger, D.L.; Wilson, I.A.PDBSumPubMed
1NJ9Crystallographic and biochemical analysis of cocaine-degrading antibody 15A10.12/30/02Larsen, N.A.; de Prada, P.; Deng, S.X.; Zhu, X.; Landry, D.W.; Wilson, I.A.PDBSumPubMed
1NCWStructural Basis for Antibody Catalysis of a Cationic Cyclization Reaction12/5/02Zhu, X.; Wilson, I.A.PDBSumPubMed
1ND0Structural Basis for Antibody Catalysis of a Cationic Cyclization Reaction12/5/02Zhu, X.; Wilson, I.A.PDBSumPubMed
1NAKRecurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop.11/27/02Stanfield, R.L.; Ghiara, J.B.; Saphire, E.O.; Profy, A.T.; Wilson, I.A.PDBSumPubMed
1N0XCrystal Structure of a Broadly Neutralizing Anti-HIV-1 Antibody in Complex with a Peptide Mimotope10/15/02Saphire, E.O.; Montero, M.; Menendez, A.; Irving, M.B.; Zwick, M.B.; Parren, P.W.H.I.; Burton, D.R.; Scott, J.K.; Wilson, I.A.PDBSumPubMed
1MWAStructural comparison of allogeneic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing V(beta) Interactions.9/27/02Luz, J.G.; Huang, M.D.; Garcia, K.C.; Rudolph, M.G.; Teyton, L.; Wilson, I.A.PDBSumPubMed
1MUJCrystal structure of MHC class II I-Ab in complex with a human CLIP peptide: Prediction of an I-Ab peptide-binding motif9/23/02Zhu, Y.; Wilson, I.A.PDBSumPubMed
1MG7XOL-1, primary determinant of sexual fate in C. elegans, is a GHMP kinase family member and a structural prototype for a class of developmental regulators8/14/02Luz, J.G.; Hassig, C.A.; Godzik, A.; Meyer, B.J.; Wilson, I.A.PDBSumPubMed
1MEJCrystal structures of human GAR Tfase of low and high pH and with substrate beta-GAR8/8/02Zhang, Y.; Desharnais, J.; Greasley, S.E.; Beardsley, G.P.; Boger, D.L.; Wilson, I.A.PDBSumPubMed
1MENCrystal structures of human GAR Tfase of low and high pH and with substrate beta-GAR8/8/02Zhang, Y.; Desharnais, J.; Greasley, S.E.; Beardsley, G.P.; Boger, D.L.; Wilson, I.A.PDBSumPubMed
1MEOCrystal structures of human GAR Tfase of low and high pH and with substrate beta-GAR8/8/02Zhang, Y.; Desharnais, J.; Greasley, S.E.; Beardsley, G.P.; Boger, D.L.; Wilson, I.A.PDBSumPubMed
1MEXAntibody Catalysis of a Bimolecular Cycloaddition Reaction8/8/02Heine, A.; Wilson, I.A.PDBSumPubMed
1M9NStructural Insights into the Avian AICAR Transformylase Mechanism.7/29/02Wolan, D.W.; Greasly, S.E.; Beardsley, G.P.; Wilson, I.A.PDBSumPubMed
1LZKOBSERVATION OF AN ARSENIC ADDUCT IN AN ACETYL ESTERASE CRYSTAL STRUCTURE6/10/02Zhu, X.; Larsen, N.A.; Basran, A.; Bruce, N.C.; Wilson, I.A.PDBSumPubMed
1LZLOBSERVATION OF AN ARSENIC ADDUCT IN AN ACETYL ESTERASE CRYSTAL STRUCTURE6/10/02Zhu, X.; Larsen, N.A.; Basran, A.; Bruce, N.C.; Wilson, I.A.PDBSumPubMed
1LV0Geranylgeranyl switching regulates GDI-Rab GTPase recycling.5/23/02An, Y.; Shao, Y.; Alory, C.; Matteson, J.; Sakisaka, T.; Chen, W.; Gibbs, R.A.; Wilson, I.A.; Balch, W.E.PDBSumPubMed
1LK2A peptide that antagonizes TCR-mediated reactions with both syngeneic and allogeneic agonists: functional and structural aspects.4/23/02Luz, J.G.; Rudolph, M.G.; Wilson, I.A.; Eisen, H.PDBSumPubMed
1LEGStructural comparison of allogeneic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing V(beta) Interactions.4/9/02Luz, J.G.; Huang, M.; Garcia, K.C.; Rudolph, M.G.; Apostolopoulos, V.; Teyton, L.; Wilson, I.A.PDBSumPubMed
1LEKStructural comparison of allogeneic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing V(beta) Interactions.4/9/02Luz, J.G.; Huang, M.; Garcia, K.C.; Rudolph, M.G.; Apostolopoulos, V.; Teyton, L.; Wilson, I.A.PDBSumPubMed
1L7QBiochemical characterization and structural analysis of a highly proficient cocaine esterase3/16/02Turner, J.M.; Larsen, N.A.; Basran, A.; Barbas III, C.F.; Bruce, N.C.; Wilson, I.A.; Lerner, R.A.PDBSumPubMed
1L7RBiochemical characterization and structural analysis of a highly proficient cocaine esterase.3/16/02Turner, J.M.; Larsen, N.A.; Basran, A.; Barbas III, C.F.; Bruce, N.C.; Wilson, I.A.; Lerner, R.A.PDBSumPubMed
1L2HUse of multiple anomalous dispersion to phase highly merohedrally twinned crystals of interleukin-1beta.2/21/02Rudolph, M.G.; Kelker, M.S.; Schneider, T.R.; Yeates, T.O.; Oseroff, V.; Heidary, D.K.; Jennings, P.A.; Wilson, I.A.PDBSumPubMed
1KQ3Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipeline1/3/02Wilson, I.A.; Miller, M.D.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
1KQ4Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipeline1/3/02Wilson, I.A.; Miller, M.D.; Joint Center for Structural Genomics (JCSG)PDBSumPubMed
1KPUHigh Resolution Crystal Structure of H-2Kb/VSV81/2/02Rudolph, M.G.; Wilson, I.A.PDBSumPubMed
1KPVHigh Resolution Crystal Structure of H-2Kb/VSV81/2/02Rudolph, M.G.; Wilson, I.A.PDBSumPubMed
1KJVCrystal structures of two rat MHC class Ia (RT1-A) molecules that are associated differentially with peptide transporter alleles TAP-A and TAP-B.12/5/01Rudolph, M.G.; Stevens, J.; Speir, J.A.; Trowsdale, J.; Butcher, G.W.; Joly, E.; Wilson, I.A.PDBSumPubMed
1KJMCrystal structures of two rat MHC class Ia (RT1-A) molecules that are associated differentially with peptide transporter alleles TAP-A and TAP-B.12/4/01Rudolph, M.G.; Stevens, J.; Speir, J.A.; Trowsdale, J.; Butcher, G.W.; Joly, E.; Wilson, I.A.PDBSumPubMed
1JU3Crystal structure of a bacterial cocaine esterase.8/23/01Larsen, N.A.; Turner, J.M.; Stevens, J.; Rosser, S.J.; Basran, A.; Lerner, R.A.; Bruce, N.C.; Wilson, I.A.PDBSumPubMed
1JU4Crystal structure of a bacterial cocaine esterase.8/23/01Larsen, N.A.; Turner, J.M.; Stevens, J.; Rosser, S.J.; Basran, A.; Lerner, R.A.; Bruce, N.C.; Wilson, I.A.PDBSumPubMed
1JKXUnexpected formation of an epoxide-derived multisubstrate adduct inhibitor on the active site of GAR transformylase.7/13/01Greasley, S.E.; Marsilje, T.H.; Cai, H.; Baker, S.; Benkovic, S.J.; Boger, D.L.; Wilson, I.A.PDBSumPubMed
1JGUStructural basis for a disfavored elimination reaction in catalytic antibody 1D4.6/26/01Larsen, N.A.; Heine, A.; Crane, L.; Cravatt, B.F.; Lerner, R.A.; Wilson, I.A.PDBSumPubMed
1JGVStructural basis for a disfavored elimination reaction in catalytic antibody 1D4.6/26/01Larsen, N.A.; Heine, A.; Crane, L.; Cravatt, B.F.; Lerner, R.A.; Wilson, I.A.PDBSumPubMed
1JCJObservation of covalent intermediates in an enzyme mechanism at atomic resolution.6/9/01Heine, A.; DeSantis, G.; Luz, J.G.; Mitchell, M.; Wong, C.-H.; Wilson, I.A.PDBSumPubMed
1JCLObservation of covalent intermediates in an enzyme mechanism at atomic resolution.6/9/01Heine, A.; DeSantis, G.; Luz, J.G.; Mitchell, M.; Wong, C.-H.; Wilson, I.A.PDBSumPubMed
1J9CLigand Induced Conformational Transitions of Tissue Factor. Crystal Structure of the Tissue Factor:Factor VIIa Complex.5/24/01Huang, M.; Ruf, W.; Edgington, T.S.; Wilson, I.A.PDBSumPubMed
1I9ECrystal structure of an isolated V(alpha) domain of the 2C T-cell receptor.3/19/01Rudolph, M.G.; Huang, M.; Teyton, L.; Wilson, I.A.PDBSumPubMed
1I7ZCrystal structure of a cocaine-binding antibody.3/12/01Larsen, N.A.; Wilson, I.A.PDBSumPubMed
1HZHCrystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design.1/24/01Saphire, E.O.; Burton, D.R.; Wilson, I.A.PDBSumPubMed
1HQ8Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A.12/14/00Wolan, D.W.; Teyton, L.; Rudolph, M.G.; Villmow, B.; Bauer, S.; Busch, D.H.; Wilson, I.A.PDBSumPubMed
1G8MCrystal structure of a bifunctional transformylase and cyclohydrolase enzyme in purine biosynthesis.11/17/00Greasley, S.E.; Horton, P.; Beardsley, G.P.; Benkovic, S.J.; Wilson, I.A.PDBSumPubMed
1G7PCrystal structure of a non-canonical high affinity peptide complexed with MHC class I: a novel use of alternative anchors.11/13/00Apostolopoulos, V.; Yu, M.; Corper, A.L.; Li, W.; McKenzie, I.F.; Teyton, L.; Wilson, I.A.PDBSumPubMed
1G7QCrystal structure of a non-canonical low-affinity peptide complexed with MHC class I: a new approach for vaccine design.11/13/00Apostolopoulos, V.; Yu, M.; Corper, A.L.; Teyton, L.; Pietersz, G.A.; McKenzie, I.F.; Wilson, I.A.PDBSumPubMed
1G6RA functional hot spot for antigen recognition in a superagonist TCR/MHC complex.11/7/00Degano, M.; Garcia, K.C.; Apostolopoulos, V.; Rudolph, M.G.; Teyton, L.; Wilson, I.A.PDBSumPubMed
1FZJThe crystal structures of K(bm1) and K(bm8) reveal that subtle changes in the peptide environment impact thermostability and alloreactivity.10/3/00Rudolph, M.G.; Speir, J.A.; Brunmark, A.; Mattsson, N.; Jackson, M.R.; Peterson, P.A.; Teyton, L.; Wilson, I.A.PDBSumPubMed
1FZKThe crystal structures of K(bm1) and K(bm8) reveal that subtle changes in the peptide environment impact thermostability and alloreactivity.10/3/00Rudolph, M.G.; Speir, J.A.; Brunmark, A.; Mattsson, N.; Jackson, M.R.; Peterson, P.A.; Teyton, L.; Wilson, I.A.PDBSumPubMed
1FZMThe crystal structures of K(bm1) and K(bm8) reveal that subtle changes in the peptide environment impact thermostability and alloreactivity.10/3/00Rudolph, M.G.; Speir, J.A.; Brunmark, A.; Mattsson, N.; Jackson, M.R.; Peterson, P.A.; Teyton, L.; Wilson, I.A.PDBSumPubMed
1FZOThe crystal structures of K(bm1) and K(bm8) reveal that subtle changes in the peptide environment impact thermostability and alloreactivity.10/3/00Rudolph, M.G.; Speir, J.A.; Brunmark, A.; Mattsson, N.; Jackson, M.R.; Peterson, P.A.; Teyton, L.; Wilson, I.A.PDBSumPubMed
1F6BCrystal structure of Sar1-GDP at 1.7 A resolution and the role of the NH2 terminus in ER export.6/21/00Huang, M.; Wilson, I.A.; Balch, W.E.PDBSumPubMed
1ES0A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes.4/7/00Corper, A.L.; Teyton, L.; Wilson, I.A.PDBSumPubMed
1ED3Two different, highly exposed, bulged structures for an unusually long peptide bound to rat MHC class I RT1-Aa.1/26/00Speir, J.A.; Stevens, J.; Joly, E.; Butcher, G.W.; Wilson, I.A.PDBSumPubMed
1C5CCatalysis of decarboxylation by a preorganized heterogeneous microenvironment: crystal structures of abzyme 21D8.11/9/99Hotta, K.; Wilson, I.A.PDBSumPubMed
1C5BCatalysis of decarboxylation by a preorganized heterogeneous microenvironment: crystal structures of abzyme 21D8.11/8/99Hotta, K.; Wilson, I.A.PDBSumPubMed
1D5TA new functional domain of guanine nucleotide dissociation inhibitor (alpha-GDI) involved in Rab recycling.10/11/99Peng, L.; Zeng, K.; Heine, A.; Moyer, B.; Greasley, S.E.; Kuhn, P.; Balch, W.E.; Wilson, I.A.PDBSumPubMed
1C3ENew insights into inhibitor design from the crystal structure and NMR studies of Escherichia coli GAR transformylase in complex with beta-GAR and 10-formyl-5,8,10-trideazafolic acid.7/27/99Greasley, S.E.; Yamashita, M.M.; Cai, H.; Benkovic, S.J.; Boger, D.L.; Wilson, I.A.PDBSumPubMed
1C2TNew insights into inhibitor design from the crystal structure and NMR studies of Escherichia coli GAR transformylase in complex with beta-GAR and 10-formyl-5,8,10-trideazafolic acid.7/26/99Greasley, S.E.; Yamashita, M.M.; Cai, H.; Benkovic, S.J.; Boger, D.L.; Wilson, I.A.PDBSumPubMed
1C1EEvolution of shape complementarity and catalytic efficiency from a primordial antibody template.7/22/99Xu, J.; Wilson, I.A.PDBSumPubMed
1C16Crystal structure of a gammadelta T cell receptor ligand T22: a truncated MHC-like fold.7/20/99Wingren, C.; Crowley, M.P.; Degano, M.; Chien, Y.; Wilson, I.A.PDBSumPubMed
1ERNCrystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation.1/11/99Livnah, O.; Stura, E.A.; Wilson, I.A.PDBSumPubMed
2F58Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs.10/23/98Stanfield, R.L.; Cabezas, E.; Satterthwait, A.C.; Stura, E.A.; Profy, A.T.; Wilson, I.A.PDBSumPubMed
3F58Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs.10/23/98Stanfield, R.L.; Cabezas, E.; Satterthwait, A.C.; Stura, E.A.; Profy, A.T.; Wilson, I.A.PDBSumPubMed
1F58Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs.10/21/98Stanfield, R.L.; Cabezas, E.; Satterthwait, A.C.; Stura, E.A.; Profy, A.T.; Wilson, I.A.PDBSumPubMed
1EBAAn antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation.10/2/98Livnah, O.; Stura, E.A.; Wilson, I.A.PDBSumPubMed
1KBGCrystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL.8/28/98Speir, J.A.; Abdel-Motal, U.M.; Jondal, M.; Wilson, I.A.PDBSumPubMed
2GARA pH-dependent stabilization of an active site loop observed from low and high pH crystal structures of mutant monomeric glycinamide ribonucleotide transformylase at 1.8 to 1.9 A.5/13/98Su, Y.; Yamashita, M.M.; Greasley, S.E.; Mullen, C.A.; Shim, J.H.; Jennings, P.A.; Benkovic, S.J.; Wilson, I.A.PDBSumPubMed
3GARA pH-dependent stabilization of an active site loop observed from low and high pH crystal structures of mutant monomeric glycinamide ribonucleotide transformylase at 1.8 to 1.9 A.5/13/98Su, Y.; Yamashita, M.M.; Greasley, S.E.; Mullen, C.A.; Shim, J.H.; Jennings, P.A.; Benkovic, S.J.; Wilson, I.A.PDBSumPubMed
15C8Ligand-Induced Conformational Changes in a Catalytic Antibody: Comparison of the Bound and Unbound Structure of Fab 5C83/18/98Gruber, K.; Wilson, I.A.PDBSumPubMed
25C8Structural basis for antibody catalysis of a disfavored ring closure reaction.3/18/98Gruber, K.; Wilson, I.A.PDBSumPubMed
35C8Structural basis for antibody catalysis of a disfavored ring closure reaction.3/18/98Gruber, K.; Wilson, I.A.PDBSumPubMed
1LDPStructural basis of 2C TCR allorecognition of H-2Ld peptide complexes.3/15/98Speir, J.A.; Wilson, I.A.PDBSumPubMed
1IAOCrystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues.3/13/98Scott, C.A.; Peterson, P.A.; Teyton, L.; Wilson, I.A.PDBSumPubMed
2IADCrystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues.3/13/98Scott, C.A.; Peterson, P.A.; Teyton, L.; Wilson, I.A.PDBSumPubMed
1A3LAn antibody exo Diels-Alderase inhibitor complex at 1.95 angstrom resolution.1/22/98Heine, A.; Wilson, I.A.PDBSumPubMed
2CKBStructural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen.1/14/98Garcia, K.C.; Degano, M.; Wilson, I.A.PDBSumPubMed
1AXTImmune versus natural selection: antibody aldolases with enzymic rates but broader scope.10/20/97Heine, A.; Wilson, I.A.PDBSumPubMed
1AHWThe mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.5G9 complex.4/10/97Huang, M.; Syed, R.; Stura, E.A.; Stone, M.J.; Stefanko, R.S.; Ruf, W.; Edgington, T.S.; Wilson, I.A.PDBSumPubMed
1FGNThe mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.5G9 complex.4/10/97Huang, M.; Syed, R.; Stura, E.A.; Stone, M.J.; Stefanko, R.S.; Ruf, W.; Edgington, T.S.; Wilson, I.A.PDBSumPubMed
1TFHThe mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.5G9 complex.4/10/97Huang, M.; Syed, R.; Stura, E.A.; Stone, M.J.; Stefanko, R.S.; Ruf, W.; Edgington, T.S.; Wilson, I.A.PDBSumPubMed
1CD1Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove.4/2/97Zeng, Z.H.; Segelke, B.W.; Wilson, I.A.PDBSumPubMed
1AI1Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site.11/6/96Ghiara, J.B.; Wilson, I.A.PDBSumPubMed
1TCRAn alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex.9/12/96Garcia, K.C.; Degano, M.; Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
1GNDStructure and mutational analysis of Rab GDP-dissociation inhibitor.7/10/96Schalk, I.; Zeng, K.; Wu, S.-K.; Stura, E.A.; Metteson, J.; Huang, M.; Tandon, A.; Wilson, I.A.; Balch, W.E.PDBSumPubMed
1EBPFunctional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A.5/7/96Livnah, O.; Stura, E.A.; Wilson, I.A.PDBSumPubMed
1GARTowards structure-based drug design: crystal structure of a multisubstrate adduct complex of glycinamide ribonucleotide transformylase at 1.96 A resolution.12/8/94Wilson, I.A.; Klein, C.; Chen, P.; Arevalo, J.H.PDBSumPubMed
1VACCrystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove.11/1/94Fremont, D.H.; Wilson, I.A.PDBSumPubMed
1VADCrystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove.11/1/94Fremont, D.H.; Wilson, I.A.PDBSumPubMed
2VAACrystal structures of two viral peptides in complex with murine MHC class I H-2Kb.11/1/94Fremont, D.H.; Wilson, I.A.PDBSumPubMed
2VABCrystal structures of two viral peptides in complex with murine MHC class I H-2Kb.11/1/94Fremont, D.H.; Wilson, I.A.PDBSumPubMed
1ACYCrystal structure of the principal neutralization site of HIV-1.2/10/94Ghiara, J.B.; Wilson, I.A.PDBSumPubMed
2DBLMolecular basis of crossreactivity and the limits of antibody-antigen complementarity.2/8/94Arevalo, J.H.; Wilson, I.A.PDBSumPubMed
1FRGCrystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen.1/17/94Churchill, M.E.A.; Wilson, I.A.PDBSumPubMed
1FIGRoutes to catalysis: structure of a catalytic antibody and comparison with its natural counterpart.1/7/94Haynes, M.R.; Stura, E.A.; Hilvert, D.; Wilson, I.A.PDBSumPubMed
1DBJMolecular basis of crossreactivity and the limits of antibody-antigen complementarity.8/24/93Arevalo, J.H.; Wilson, I.A.PDBSumPubMed
1DBKMolecular basis of crossreactivity and the limits of antibody-antigen complementarity.8/24/93Arevalo, J.H.; Wilson, I.A.PDBSumPubMed
1DBMMolecular basis of crossreactivity and the limits of antibody-antigen complementarity.8/24/93Arevalo, J.H.; Wilson, I.A.PDBSumPubMed
1GGBMajor antigen-induced domain rearrangements in an antibody.7/19/93Takimoto-Kamimura, M.; Wilson, I.A.PDBSumPubMed
1GGCMajor antigen-induced domain rearrangements in an antibody.7/19/93Takimoto-Kamimura, M.; Wilson, I.A.PDBSumPubMed
1IFHDetailed analysis of the free and bound conformations of an antibody. X-ray structures of Fab 17/9 and three different Fab-peptide complexes.5/6/93Schulze-Gahmen, U.; Wilson, I.A.PDBSumPubMed
1GGICrystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen.4/2/93Stanfield, R.L.; Rini, J.M.; Wilson, I.A.PDBSumPubMed
1DBBThree-dimensional structure of an anti-steroid Fab' and progesterone-Fab' complex.11/11/92Arevalo, J.H.; Wilson, I.A.PDBSumPubMed
1DBAThree-dimensional structure of an anti-steroid Fab' and progesterone-Fab' complex.11/10/92Arevalo, J.H.; Wilson, I.A.PDBSumPubMed
1PSHCrystal structure of phospholipase A2 from Indian cobra reveals a trimeric association.7/28/92Fremont, D.; Xuong, N.-H.; Wilson, I.PDBSumPubMed
1GRCCrystal structure of glycinamide ribonucleotide transformylase from Escherichia coli at 3.0 A resolution. A target enzyme for chemotherapy.7/21/92Chen, P.; Wilson, I.A.PDBSumPubMed
1HILStructural evidence for induced fit as a mechanism for antibody-antigen recognition.7/8/92Rini, J.M.; Wilson, I.A.PDBSumPubMed
1HIMStructural evidence for induced fit as a mechanism for antibody-antigen recognition.7/8/92Schulze-Gahmen, U.; Wilson, I.A.PDBSumPubMed
1HINStructural evidence for induced fit as a mechanism for antibody-antigen recognition.7/8/92Rini, J.M.; Wilson, I.A.PDBSumPubMed
1IGFCrystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 A.3/21/91Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
2IGFCrystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 A.3/21/91Stanfield, R.L.; Wilson, I.A.PDBSumPubMed
1TIMAtomic coordinates for triose phosphate isomerase from chicken muscle.9/1/76Banner, D.W.; Bloomer, A.C.; Petsko, G.A.; Phillips, D.C.; Wilson, I.A.PDBSumPubMed
The Scripps Research Institute
Gravityscan Badge